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play central roles in such networks by binding to core promoters and regulatory elements and thereby
controlling transcription activities and chromatin states in the genome. GATA1 is a hematopoietic
transcription factor that controls multiple hematopoietic lineages by activating and repressing gene
expression, yet the in vivo mechanisms that specify these opposing activities are unknown. By examining
the composition of GATA1 associated protein complexes in a genetic complementary erythroid cell
system as well as through the use of tiling arrays, we found that a multi-protein complex containing SCL/
TAL1, LMO2, Ldb1, and E2A (the SCL complex thereafter) is present at most sites where GATA1 functions
as an activator but depleted at most repressive GATA1 sites. Functional interference of the SCL complex
selectively impairs activation but not repression by GATA1. These results identify the SCL complex as a
critical and consistent determinant of positive GATA1 activity. The SCL complex and GATA1 co-occupy
the active &beta-globin promoter and the distant locus control region (LCR), which are juxtaposed into
close proximity by chromatin looping. The physical interaction of genes with their cis-regulatory elements
are commonly observed in the metazoan genome, however, the molecular architecture of loop formation
and the cause-effect relationship between transcription and looping remain unclear. A few lines of
evidence suggest Ldb1, one component of the SCL complex, mediates GATA1 induced chromatin looping.
To manipulate chromatin loop formation, we employed artificial zinc fingers (ZF) to tether Ldb1 to the
&beta-globin promoter in GATA1 null erythroblasts in which the &beta-globin locus is relaxed and inactive.
Remarkably, targeting Ldb1 or only its self-association domain to the &beta-globin promoter substantially
activated &beta-globin transcription in the absence of GATA1. Promoter-tethered Ldb1 interacted with
endogenous Ldb1 complexes at the LCR to form a chromatin loop, causing recruitment and
phosphorylation of RNA polymerase II. ZF-Ldb1 proteins were inactive in primary erythroblasts with LCR
deletion, demonstrating that their activities depend on long-range interactions. Our findings establish
Ldb1 as critical effector of GATA1-mediated loop formation and indicate that chromatin looping causally
underlies gene regulation. Our studies have for the first time forced long-range chromatin looping at a
native locus and provide a novel approach to manipulate gene activity in cells.
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ABSTRACT
HIGHER-ORDER CHROMATIN ORGANIZATION
IN HEMATOPOIETIC TRANSCRIPTION
Wulan Deng
Gerd A. Blobel
Coordinated transcriptional networks underlie complex developmental processes.
Transcription factors play central roles in such networks by binding to core promoters
and regulatory elements and thereby controlling transcription activities and chromatin
states in the genome. GATA1 is a hematopoietic transcription factor that controls
multiple hematopoietic lineages by activating and repressing gene expression, yet the in
vivo mechanisms that specify these opposing activities are unknown. By examining the
composition of GATA1 associated protein complexes in a genetic complementary
erythroid cell system as well as through the use of tiling arrays, we found that a multiprotein complex containing SCL/TAL1, LMO2, Ldb1, and E2A (the SCL complex
thereafter) is present at most sites where GATA1 functions as an activator but depleted at
most repressive GATA1 sites. Functional interference of the SCL complex selectively
impairs activation but not repression by GATA1. These results identify the SCL complex
as a critical and consistent determinant of positive GATA1 activity. The SCL complex
and GATA1 co-occupy the active β-globin promoter and the distant locus control region
(LCR), which are juxtaposed into close proximity by chromatin looping. The physical
interaction of genes with their cis-regulatory elements are commonly observed in the
v

metazoan genome, however, the molecular architecture of loop formation and the causeeffect relationship between transcription and looping remain unclear. A few lines of
evidence suggest Ldb1, one component of the SCL complex, mediates GATA1 induced
chromatin looping. To manipulate chromatin loop formation, we employed artificial zinc
fingers (ZF) to tether Ldb1 to the β-globin promoter in GATA1 null erythroblasts in
which the β-globin locus is relaxed and inactive. Remarkably, targeting Ldb1 or only its
self-association domain to the β-globin promoter substantially activated β-globin
transcription in the absence of GATA1. Promoter-tethered Ldb1 interacted with
endogenous Ldb1 complexes at the LCR to form a chromatin loop, causing recruitment
and phosphorylation of RNA polymerase II. ZF-Ldb1 proteins were inactive in primary
erythroblasts with LCR deletion, demonstrating that their activities depend on long-range
interactions. Our findings establish Ldb1 as critical effector of GATA1-mediated loop
formation and indicate that chromatin looping causally underlies gene regulation. Our
studies have for the first time forced long-range chromatin looping at a native locus and
provide a novel approach to manipulate gene activity in cells.
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CHAPTER 1: INTRODUCTION
The identity and function of a cell are determined by its specific transcription
program. Transcription is a highly regulated process that involves the interaction and
combinatorial action of tissue-specific transcription factors and basal transcription
machinery on chromatin, selectively activating or repressing specific groups of genes. A
fundamental question remains: how do numerous transcription factors coordinate to
specify transcription activities of their target genes? Moreover, in metazoans, many
transcription factors regulate gene expression by binding to distal cis-regulatory elements
that can be spaced kilobases and megabases from the promoters. These distant elements
are found to physically interact with their target genes with intervening chromatin looped
out, forming so called “chromatin loop” structures. Despite that many factors are known
to be involved and/or required for chromatin loop formation, the molecular forces that
configure the chromatin fiber and importantly the cause-effect relationship between
chromatin looping dynamics and transcription regulation are still enigmatic. This thesis
probes these important questions by studying the transcriptional network of
hematopoietic cells and investigating the molecular mechanisms of chromatin looping at
a model locus, the β-globin locus.

1

1.1: Transcriptional Network of Hematopoiesis
1.1.1: Hematopoietic development
Hematopoiesis is the process by which blood cells arise from the pluripotent
hematopoietic stem cells (HSC). It is a complex, multistage process that begins during
embryonic development and continues throughout adulthood to sustain all lineages of
blood cells. In mammals, hematopoiesis occurs first in the yolk sac blood islands, then
the aorta-gonad mesonephros region and the placenta (known as primitive hematopoiesis)
and later in the fetal liver and finally the bone marrow (know as definitive hematopoiesis)
(for review, see (Orkin and Zon, 2008); Figure 1.1). At these sites, instructed by extrinsic
signals, HSCs develop into multipotential progenitors, committed precursors, and
eventually differentiate into specific hematopoietic lineages. For example, red blood cells
and megakaryocytes arise from a common precursor, the megakaryocyte-erythroid
progenitor. This process is orchestrated by a number of lineage-restricted transcription
regulators, including GATA1, FOG1, SCL/TAL1, KLF1/EKLF and Gfi-1b, together with
various ubiquitously expressed transcriptional factors (for review, see (Hattangadi et al.,
2011)). These regulators are found in numerous combinations of multi-protein complexes
and are essential to ensure normal erythroid commitment and maturation, i.e. to activate
lineage-specific genes and to simultaneously suppress genes associated with immature
stages and alternative lineages.
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Figure 1.1. Murine hematopoiesis (From (Orkin and Zon, 2008)). During
development hematopoiesis occurs sequentially at indicated sites (A) and favors the
production of specific blood lineages (B).

1.1.2: GATA transcription factors
(i). GATA1
GATA factors comprise a family of zinc finger transcription factors controlling
diverse developmental processes in vertebrates and invertebrates (Patient and McGhee,
2002). GATA proteins directly bind to the WGATAR consensus sequence and interact
with various co-factors via its two highly conserved zinc finger domains. GATA1, the
founding member of the GATA family, is essential for the normal development of
3

erythroid cells, megakaryocytes, mast cells and eosinophil granulocytes (Crispino, 2005).
Loss of GATA1 in mice leads to embryonic death at around day 11.5 due to failure to
produce mature erythroid cells (Fujiwara et al., 1996). Both a block in differentiation and
apoptosis account for the observed lack of mature erythroid cells in GATA1 null mice
(Weiss and Orkin, 1995; Weiss et al., 1997). Tissue-specific loss of GATA1 in mice
leads to an arrest in megakaryocytic maturation associated with decreased platelet
production and deregulated proliferation of immature megakaryocytes (Shivdasani et al.,
1997). Importantly, mutations or rearrangements in the human GATA1 gene contribute to
various hematological disorders including leukemias and congenital anemias. For
example, point mutations in the N-terminal zinc finger of GATA1 are found in patients
with X-linked anemia and thrombocytopenia (Nichols et al., 2000). Moreover, mutations
in the GATA1 gene that lead to production of an N-terminally truncated GATA1 protein
contribute to megakaryoblastic leukemias in patients with Down Syndrome (Wechsler et
al., 2002). These disease-causing mutations of GATA1 interfere with the interaction of
GATA1 with its co-factors, underlining the importance of co-factors in determining
GATA1 activity.
Our understanding of the mechanisms of GATA1 function has been greatly aided by
the use of the GATA1 null erythroid cell line G1E (Weiss et al., 1997). G1E cells were
derived from GATA1 null ES cells and are arrested at the immature proerythroblast stage
due to the absence of GATA1. GATA1 fused to the ligand binding domain of the
estrogen receptor (GATA1-ER) was introduced to G1E cells (G1E-ER4 cells), providing
a convenient inducible system to study GATA1 function in erythroid differentiation.
4

Treatment with estradiol or tamoxifen leads to activation of GATA1 protein and
subsequently completion of erythroid differentiation as reflected by synchronous cell
cycle arrest, expression of erythroid genes, including the α- and β-globin genes, and
repression of genes associated with immature stages and proliferation (Weiss et al.,
1997). Whole genome expression studies have revealed that differentiating G1E cells
mimic the normal erythroid maturation program with high fidelity (Cheng et al., 2009;
Fujiwara et al., 2009; Welch et al., 2004), therefore G1E cells provide a physiologically
relevant assay for the functions of GATA1 in its natural environment.
(ii). GATA2 and GATA switch
The dual zinc finger domains of GATA factors are highly conserved among the six
mammalian proteins, while the N and C termini are divergent. GATA2, another essential
regulator of hematopoiesis, binds to the WGATAR motif and shares many chromatin
binding sites with GATA1. Although GATA1 and GATA2 share many co-factors
including FOG1 and the SCL complex, they display different and often opposing
activities at particular target genes. In contrast to GATA1 which drives hematopoietic
differentiation, GATA2 is closely linked to the emergence and maintenance of
hematopoietic stem cells and multiple hematopoietic progenitors (Rodrigues et al., 2012).
During erythroid development, GATA1 directly represses Gata2 transcription, and
GATA1 displaces GATA2 from chromatin of its target genes, a process termed “GATA
switch” (Bresnick et al., 2010). Such switches occur at numerous loci and correlate with
alteration of transcription activity. The divergent N and C termini confer differential
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stabilities to GATA1 and GATA2, with GATA1 being more stable than GATA2,
providing a possible mechanism to ensure efficient GATA switches (Lurie et al., 2008).
1.1.3: GATA1 co-factors
GATA1 associates with many tissue-specific or ubiquitously-expressed transcription
factors through direct interaction or as components of multi-protein complexes
(Rodriguez et al., 2005). The challenge has been to sort out which of these interactions
are functionally significant, determine the mechanisms by which they modulate GATA1
activity, and understand how they relate to one another.
(i). FOG1/NuRD
Many co-factors associate with GATA1 and modulate its activity (Rodriguez et al.,
2005). FOG1 is the first known tissue-specific GATA1 co-factor. It binds to the Nterminal zinc finger of GATA1 (Tsang et al., 1997). FOG1 is recruited to virtually all
sites occupied by GATA1 and is essential for the differentiation of multiple GATA1regulated hematopoietic lineages. Physical interaction of GATA1 and FOG1 is required
for GATA1 chromatin occupancy at a subset of its target sites (Letting et al., 2004; Pal et
al., 2004), and for the long-range chromatin interaction of the LCR and the active
promoter at the β-globin locus (Vakoc et al., 2005). FOG1 interacts tightly with the
histone deacetylase complex NuRD, providing a mechanism for GATA1-dependent gene
repression (Hong et al., 2005). However, ChIP studies found that the NuRD complex is
present at both active and repressed genes (Miccio et al., 2010), leaving open the
possibility that other mechanisms may determine the repressive activity of GATA1.
6

Nevertheless, interaction of FOG1 and NuRD is important since disruption of FOG1
binding to NuRD leads to defects in erythroid and megakaryocyte development in mice
(Miccio et al., 2010).
(ii). CBP/Brd3
GATA1 also interacts directly with the lysine acetyltransferase CBP (Blobel et al.,
1998). GATA1 is acetylated by CBP at two conserved lysine clusters C-terminal to its
two zinc finger domains in vitro and in cells (Boyes et al., 1998; Hung et al., 1999).
Acetylation of GATA1 is required for its chromatin occupancy but dispensable for its
nuclear localization, protein stability and DNA binding (Boyes et al., 1998; Lamonica et
al., 2006). Bromodomain-containing protein 3, Brd3, was recently identified as a novel
co-factor of GATA1, recognizing acetylated lysine residues of GATA1 via its first
bromodomain (Lamonica et al., 2011). Brd3 is recruited to both active and repressed
GATA1 targets, regardless of the histone acetylation state. Its interaction with acetylated
GATA1 is important for chromatin association of GATA1 and erythroid maturation
(Lamonica et al., 2011).
(iii). SCL/LMO2/Ldb1/E2A/GATA multi-protein complex
A protein complex composed of SCL, LMO2, Ldb1, and E2A can physically and
functionally associate with GATA factors in normal and leukemic blood cells (Lecuyer
and Hoang, 2004) (Figure 1.2). LMO2 functions as a scaffold protein bridging the two
DNA-binding proteins, SCL and GATA, via direct interaction (Goardon et al., 2006;
Osada et al., 1995; Schuh et al., 2005; Wadman et al., 1997). In erythroid cells, GATA1
7

and SCL synergistically transactivate transcription at many erythroid-specific genes.
Tandem GATA-E-box elements separated by 9 to 12 base pairs were found at their
binding sites at some critical erythroid genes including Klf1 (Anderson et al., 1998),
Gata1 (Nishimura et al., 2000; Vyas et al., 1999), p4.2 (Xu et al., 2003) and GPA (Lahlil
et al., 2004).

Figure 1.2 Schematic model of the SCL/GATA complex (from (El Omari et al.,
2011)).

SCL is an essential transcriptional regulator in normal hematopoiesis. It is the most
frequent target of chromosomal rearrangement in children with T-cell acute
lymphoblastic leukemia (T-ALL) (Begley and Green, 1999). SCL null ES cells fail to
contribute to all hematopoietic lineages in adult chimeric mice, and SCL null mice die
during embryogenesis with a complete absence of yolk sac blood, indicating that SCL
plays an essential role in early hematopoiesis (Porcher et al., 1996; Robb et al., 1995;
Shivdasani et al., 1995). Conditional knockout experiments, which bypass the embryonic
lethality, have demonstrated that SCL is also vital for erythroid and megakaryocytic
8

differentiation (Mikkola et al., 2003). Like other members of the bHLH family, SCL
heterodimerizes with E proteins such as E2A (E12 and E47) through HLH domain, and
binds DNA in the major groove on consensus E-box motifs CANNTG via residues in
their basic (b) domain. Within the basic domain, three highly conserved residues RER
(195-197) are required for DNA binding and substitution of these three residues by
alanines disrupts DNA binding of SCL (Porcher et al., 1999). Notably, the DNA-binding
activity of SCL is dispensable for specification of primitive and definitive hematopoiesis,
but is required for complete erythroid maturation (Kassouf et al., 2008; Porcher et al.,
1999). Strikingly, a small fraction of mice homozygous for a DNA-binding-defective
form of SCL (SCL-RER) survived to adulthood (Kassouf et al., 2008). Like most
transcriptional regulators, SCL can function as an activator or repressor. The latter
function is controlled at least in part through interaction with the transcriptional corepressor ETO-2 (Goardon et al., 2006; Meier et al., 2006; Schuh et al., 2005).
Ldb, LIM-domain binding protein, is a family of evolutionarily conserved nuclear
factors that are widely expressed throughout embryonic and adult tissues (Matthews and
Visvader, 2003). The founding member Ldb1 was originally identified as a co-factor of
LIM-homeodomain and LIM-only (LMO) proteins that have fundamental roles in
development. Ldb1 interacts with the LIM-containing protein through its LIM-interaction
domain (LID). Ldb1 can self-associate to form dimer or oligomers (Cross et al., 2010),
which might underlie its functions in transcription regulation (see below).
Ldb1 functions as a multi-adaptor protein mediating interactions between many
different classes of lineage-specific transcription factors and thus plays important roles in
9

cell fate determination and differentiation (Matthews and Visvader, 2003). It is essential
for normal secondary axis formation in Xenopus embryos, and for normal segmentation,
neuronal axon guidance and wing morphology in Drosophila. Deletion of Ldb1 in mice
causes severe patterning defects during gastrulation and mutant embryos die around E9.5
(Mukhopadhyay et al., 2003), indicating Ldb1 plays evolutionarily conserved roles in
development. In hematopoietic cells, Ldb1 is found to mostly function in the SCL/GATA
complex (this study and (Li et al., 2011)). There is a critical and continuous requirement
for Ldb1 in hematopoiesis. It is required for the maintenance of both fetal and adult
mouse HSCs, as well as for the commitment and differentiation of erythroid cells and
megakaryocytes.

1.2: Higher-order Chromatin Organization
1.2.1: Features of genome organization
The eukaryotic genome is organized in the cell nucleus to fit the spatial constraints
and at the same time allow for access of regulatory factors to the underlying DNA
sequences. The first layer of organization involves the winding of 147 base pairs of DNA
around the histone octamer to form a nucleosome, the crystal structure of which has been
solved (Luger et al., 1997). A string of nucleosomes without any further folding presents
itself as an 11 nm fiber under the electron microscope. The next layer of packaging
involves the helical stacking of nucleosomes to form a chromatin fiber with a diameter of
~30 nm, of which the structural organization is beginning to be unraveled (Robinson and
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Rhodes, 2006). The architecture of the chromatin fiber at the next higher level is much
more obscure. Direct visualization by microscopy and DNA fluorescence in situ
hybridization (FISH) suggests that individual chromosomes occupy a defined volume and
territory of the nucleus but can overlap with their immediate neighbors and contact even
farther regions in the nucleus (Cremer et al., 2006). Recent genomic studies combining
chromosome conformation capture (3C) with high-throughput sequencing have been used
to construct comprehensive maps of spatial proximity within mammalian genomes
(Dixon et al., 2012; Lieberman-Aiden et al., 2009). These maps confirmed the presence
of chromosome territories and identified thousands of megabase-sized local chromatin
interaction domains with distinct boundaries, termed as “topological domains” (Dixon et
al., 2012; Lieberman-Aiden et al., 2009). Surprisingly, these domains are largely
unchanged across different cell types regardless of cell differentiation states and are
highly conserved across mouse and human ES cells. These findings suggest that
topological domains may present a general folding principle of chromosomes that might
be determined by intrinsic properties of the genome and can be largely inherited
throughout cell cycle and cell differentiation. The insulator binding protein CTCF, active
housekeeping genes, transfer RNAs and SINE retrotransposons were found enriched at
the boundaries of topological domains, indicating that these factors may have a role in
establishing such genomic organization (Dixon et al., 2012; Lieberman-Aiden et al.,
2009). However, it is still to be further investigated whether these observations hold true
for a broader spectrum of cell types.
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1.2.2: Mechanisms of remote gene activation
Enhancers were originally identified as cis-acting DNA sequences that increase
transcription in a manner that is independent of their orientation and distance relative to
the transcription start site (Blackwood and Kadonaga, 1998). In metazoan cells, gene
activity is often under control of distal enhancers that can be up to hundreds of kilobases
from the gene promoter. A key question is how enhancer elements communicate over
long genomic distance with the target genes to regulate transcription activity (Bulger and
Groudine, 2011). Proposed mechanistic models fall into two categories (Blackwood and
Kadonaga, 1998; Bulger and Groudine, 1999). One is a non-contact model proposing that
enhancers act at a distance to create a favorable environment for transcription, or to act as
nucleation sites for transcription factors and RNA polymerase to spread along the
chromatin fiber to reach the promoters (also called the “tracking” model, Figure 1.3 A).
There are only a few studies in support of this model, and it is not clear in this model
what mediates the spreading of transcription factors and RNA polymerase along the
chromatin, what determines the direction of spreading and what prevents the unintended
activation of intervening genes. The other model is a contact model proposing that longrange communication occurs through direct and specific interactions between the distant
enhancers and the promoters of regulated genes, without involvement of the intervening
chromatin fiber (Figure 1.3 B). The contact model predicts a looped configuration of
chromatin fiber in which distant enhancers and genes are juxtaposed into physical
proximity and intervening chromatin is looped out. Such looped conformations have been
observed at many loci thanks to the invention of chromosome conformation capture assay
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(3C) (Cullen et al., 1993; Dekker et al., 2002) that allows a direct assessment of
chromatin interactions. The use of 3C and its high-throughput derivatives have revealed
juxtaposition of genomic distant DNA elements, i.e. chromatin looping, as a general
principle of chromatin organization and enhancer-promoter communication (for review
see (Dean, 2011; Kadauke and Blobel, 2009; Miele and Dekker, 2008; Schoenfelder et
al., 2010a; Sexton et al., 2009)). Nevertheless, the tracking model and looping model are
not mutually exclusive but a possible scenario remains that chromatin tracking proceeds
and facilitates the formation of chromatin loops.
Enhancers regulate gene expression by diverse manners and mechanisms (Bulger and
Groudine, 2011). It is widely observed in vertebrates and invertebrates that transcription
activity of a gene can be regulated by multiple enhancers. At some genes, individual
enhancers drive distinct expression patterns of a gene independent of other enhancers
(e.g. tissue-specific expression). Whereas at other genes, multiple enhancers are activated
simultaneously by the same transcription factors and robustly promote active
transcription in similar spatio-temporal patterns. The functions of co-regulated enhancers
can be non-redundant and additive such as the β-globin enhancers (see Chapter 1.3), or
apparently redundant or semi-redundant such as shadow enhancers found in Drosophila
(for review see (Barolo, 2012)). Multiple distant enhancers are found to interact with
their active target genes simultaneously, thus forming an “active chromatin hub” structure
containing multiple chromatin loops at a locus (for example, the β-globin (see Figure 1.6)
and Hox loci (Montavon et al., 2011)). It is speculated that clustering of multiple
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enhancers could achieve and maintain a high local concentration of transcription factors
and RNA polymerase for promoting transcription activity.

A. Non-contact model

B. Contact model

Figure 1.3. Mechanistic models for long-range transcription control.
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Long-range chromatin interactions are not limited to regulatory elements on the same
chromosome (cis) but have also been observed across different chromosomes (trans)
although their functions remain largely obscure (Williams et al., 2010). Moreover,
chromatin looping is also present at repressed genes. For example, upon repression of the
Kit gene, loss of an enhancer-promoter loop is accompanied by de novo formation of a
loop within the gene body (Jing et al., 2008). Polycomb group (PcG) protein occupied
regions can form chromatin loops and maintain key developmental regulatory genes in
poised, low transcription state in early embryonic cells (Tiwari et al., 2008). The work
presented here focuses on active chromatin looping in cis.
1.2.3: Molecular mediators of chromatin looping
The chromatin looping model presumes that the chromatin fiber is flexible and that
enhancers and genes are relatively free to move in three dimensions to contact each other
within the nucleus. However, it is still unknown how enhancers “find” their target genes
efficiently, how enhancers confine their activity to a specific gene, and what molecular
forces tie the loops. Chromatin loops can span kilobases to megabases of genomic
distance, so it appears unlikely that unassisted looping would be either efficient or
specific (Rippe, 2001). Yet the composition of protein complexes bound to the regulatory
element and the regulated gene are likely to determine affinity and specificity of longrange interactions. Cell-type specific transcription factors and their associated co-factors
are plausible candidates of mediating chromatin loops that are linked to cell-type specific
transcription. Interactions of specific factor-associated chromatin can be mapped by the
ChIP-loop assay or ChIA-PET (chromatin interaction analysis by paired-end tag
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sequencing) on a genome-wide scale (Hakim and Misteli, 2012). The first ChIA-PET
study in human breast cancer cells reveals that a large portion of remote estrogen receptor
α (ERα) binding sites with high ChIP signal are juxtaposed with gene promoters through
long-range chromatin interactions, suggesting ERα regulates transcription activity by
inducing extensive chromatin looping to bring enhancers and genes together (Fullwood et
al., 2009). 3C and loss-of-function studies have documented numerous examples that
DNA-binding transcription factors and their co-factors are required in chromatin loop
formation (e.g. β-globin locus, see below). However, chromatin binding of transcription
factors and co-factors are often inter-dependent, making it difficult to determine whether
chromatin looping is a direct or indirect function of a particular factor, and to determine
which factor, if any, is sufficient to establish chromatin loops.
A few ubiquitously expressed nuclear factors have been implicated in mediating
gene-specific chromatin loops. CCCTC-binding factor (CTCF) is a highly conserved
DNA binding protein and involved in diverse regulatory functions including transcription
activation/repression,

insulation,

and

imprinting

(Phillips

and

Corces,

2009).

Accumulating data by studying specific loci suggest that CTCF functions at least in part
via mediating long-range chromatin interactions (Hou et al., 2010; Splinter et al., 2006;
Yoon et al., 2007). Recent genome-wide studies support a primary role for CTCF in
global organization of chromatin architecture (Handoko et al., 2011). Cohesin and
Mediator physically interact in murine embryonic stem cells (Kagey et al., 2010). They
co-occupy numerous active enhancers and promoters that are found to form chromatin
loops (Kagey et al., 2010). However, it is still not fully understood how these factors are
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involved in the formation and maintenance of chromatin looping, and how they interact
with lineage-constrained transcription factors to establish cell-specific chromatin
interactions.

1.3: β-Globin Regulation
1.3.1: Composition of the β-globin locus
Studies of the β-globin locus have often been at the forefront of revealing new
mechanisms of gene regulations. The mammalian β-globin loci are highly conserved and
share similar genomic composition among species. The mouse β-globin locus contains
four functional globin genes arranged in the order of their temporal expression, with two
embryonic globin genes, εy and βh1, followed by two adult globin genes, β-major and βminor (Figure 1. 4 A). Upstream of the β-globin genes lies a cluster of conserved DNase I
hypersensitive sites (HSs), called the locus control region (LCR). The HSs of LCR
function as erythroid-specific enhancers and confer high-level expression of β-globin
genes in erythroid cells. Additional HSs are found both upstream and downstream of the
LCR and globin genes (Figure 1. 4 A). The human β-globin locus has similar genomic
organization as the mouse locus but contains five functional globin genes in the order of
5’-ε-Gγ-Aγ-δ-β-3’. ε, Gγ and Aγ, δ and β, are expressed in embryonic, fetal and adult
stages, respectively (Figure 1. 4 B). Point mutations or deletions of the LCR or β-globin
genes are found in humans and lead to β-thalassemia with a large spectrum of disease
severity. The first “molecular disease” sickle cell anemia (SCD) is caused by substitution
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of valine for glutamic acid in the human β-globin chain. The mutant hemoglobin (HbS)
undergoes polymerization upon deoxygenation, resulting in erythrocyte deformation and
hemolysis.

(A)

(B)

Figure 1. 4. The mouse and human β-globin loci (From (Palstra et al., 2008a)). HS,
DNase I hypersensitive site. OR, olfactory receptor genes.
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1.3.2: LCR of the β-globin locus
LCRs are defined by their ability to confer high-level and tissue-specific expression
of linked genes in a copy number-dependent manner at ectopic chromatin sites (for
review, see (Li et al., 2002)). The LCR was first identified at the human β-globin locus.
When the LCR is missing, transcription of β-globin is severely reduced (Bender et al.,
2000). Functions of each HS element at the mouse β-globin locus have been extensively
studied by gene-targeting in mice (Bender et al., 2012; Bender et al., 1998; Bender et al.,
2001; Fiering et al., 1995). Deletion of individual HS leads to reduction of β-globin
expression to various extents, ranking as HS2>HS3>HS4>HS1 ((Bender et al., 2012),
Figure 1.5). HS2 functions as a classical enhancer as it shows activity in transient
transfection assays. HS5 and HS6 do not show direct roles in β-globin activation
although HS5 is homologous to the bona fide insulator element, chicken HS4 (Bender et
al., 2012; Bender et al., 1998). Deletion of multiple HSs shows additive and not
synergistic effects on transcription (Bender et al., 2012). These findings support that HSs
of the β-globin LCR function in an additive manner in the mouse. Although the LCR is
essential for high-level expression of β-globin, the open chromatin structure (Epner et al.,
1998; Reik et al., 1998), hyperacetylation of histones (Schubeler et al., 2001) and
developmental gene switching (Bender et al., 2000; Epner et al., 1998) are independent of
the LCR.
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Figure 1.5 Effect of single HS deletions on β-globin expression (from (Bender et al.,
2012)).

1.3.3: Chromatin organization of the β-globin locus
The LCR resides 20-60 kilobases upstream of β-globin genes. How the LCR exerts its
function on β-globin transcription over a long genome distance and how such spatial- and
temporal- regulation is achieved have been long-standing and interesting questions.
Studies of its chromatin organization have provided valuable insights. Two independent
studies demonstrated that the β-globin LCR and the active adult β-major globin promoter
are in close proximity in adult erythroid cells, suggesting that these two regions
physically interact supporting the chromatin looping model (Carter et al., 2002; Tolhuis
et al., 2002). In primitive erythroid cells, a development stage when the embryonic globin
genes are active and the adult globin genes are silent, the LCR interacts specifically with
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the active embryonic globin genes but not the adult globin genes (Palstra et al., 2003).
These observations linked the LCR-globin gene interactions with active transcription.
The flanking upstream and downstream HSs are also found to be in proximity with the
LCR and the active globin genes, forming an active chromatin hub structure ((Palstra et
al., 2003), Figure 1.6). The globin genes switch their interaction with the LCR,
correlating with the switch of their activity during development. Moreover, the spatial
organization of the β-globin locus is cell type-specific. The β-globin locus adopts a
seemingly linear conformation in brain cells, but forms a partial chromatin hub structure
in erythroid progenitor cells before full transcription activation (Figure 1.6).

Figure 1.6 The β-globin chromatin hub (From (Palstra et al., 2003)).

A number of nuclear factors are involved in chromatin looping at the β-globin locus.
CTCF binds multiple HSs flanking the β-globin locus: the upstream HS-85, HS-62/60,
HS5 and the downstream 3’HS {Splinter, 2006 #1182}. Interactions among these CTCF21

binding elements are formed prior to full activation of β-globin and participate in the
ACH in mature erythroid cells (Figure 1.6). Conditional deletion of CTCF or targeted
deletion of its DNA-binding site in erythroid progenitor destabilizes interactions among
CTCF-bound HSs, however, LCR-promoter interactions and transcription activation are
not affected {Splinter, 2006 #1182}. Mechanistic studies defined gene-specific
transcription

factors

that

establish

LCR-β-globin

interactions,

including

the

hematopoietic-restricted factors GATA1 and its co-factor FOG1 (Vakoc et al., 2005),
KLF1 (Drissen et al., 2004), and the more broadly expressed protein Ldb1 (Song et al.,
2007). Functional disruption of any of these factors was associated with reduced LCR-βglobin interactions and diminished β-globin transcription. It is still not fully understood
how these factors interplay on chromatin and organize the higher-order chromatin
structure.
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CHAPTER 2: SCL and Associated Proteins
Distinguish Active from Repressive GATA
Complexes

Research presented in this chapter was accomplished in collaboration with a previous
postdoctoral fellow, Tamara Tripic, with equal contribution. I have contributed to the
experimental design and execution, and manuscript writing for the publication. I have
worked together with Tamara to characterize the dynamic association of the SCL
complex with chromatin at various loci and in multiple hematopoietic cell lineages
(Figure 2.1-2.8). I have examined chromatin recruitment of the DNA binding mutant
SCL by GATA1 (Figure 2.9), analyzed the ChIP-chip results with our collaborator Ross
Hardison laboratory (Figure 2.10), and investigated effects of LMO2 knockdown to
GATA1 activity (Figure 2.11).
This research was originally published in Blood. Tamara Tripic*, Wulan Deng*,
Yong Cheng, Ying Zhang, Christopher R. Vakoc, Gregory D. Gregory, Ross C.
Hardison, and Gerd A. Blobel. SCL and associated proteins distinguish active from
repressive GATA transcription factor complexes. Blood 2009 113:2191-2201. © the
American Society of Hematology. *equal contribution
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2.1: Chapter Summary
GATA1 controls hematopoietic development by activating and repressing gene
transcription, yet the in vivo mechanisms that specify these opposite activities are
unknown. To our surprise, we found that active and repressive GATA1 complex cannot
be distinguished simply by its association with classical co-activator CBP/p300 or corepressor NuRD complex. By examining the composition of GATA1 associated protein
complexes in a conditional erythroid rescue system as well as through the use of tiling
arrays we detected the SCL, LMO2, Ldb1, E2A complex at all positively acting GATA1bound elements examined. Similarly, the SCL complex is present at all activating GATA
elements in megakaryocytes and mast cells. In striking contrast, at sites where GATA1
functions as a repressor, the SCL complex is depleted. A DNA-binding defective form of
SCL maintains association with a subset of active GATA elements indicating that
GATA1 is a key determinant for SCL recruitment. Knockdown of LMO2 selectively
impairs activation but not repression by GATA1. ETO-2, an SCL-associated protein with
the potential for transcription repression is also absent from GATA1-repressed genes but,
unlike SCL, fails to accumulate at GATA1 activated genes. Together, these studies
identify the SCL complex as a critical and consistent determinant of positive GATA1
activity in multiple GATA1-regulated hematopoietic cell lineages.
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2.2: Introduction
Most transcription factors can function both as activators and repressors. The context
that determines transcriptional activity is often unclear. This holds true for GATA1,
which in erythroid cells activates all known erythroid-specific genes but also contributes
to the repression of genes associated with the immature, proliferative state. The proper
balance of GATA1's activating and repressive functions is essential for normal
hematopoietic cell maturation, and its disruption contributes to diseases with underlying
GATA1 mutations (Hollanda et al., 2006; Nichols et al., 2000; Wechsler et al., 2002).
Many co-factors associate with GATA1 and modulate its activity. GATA1 interacts
with the NuRD complex, a classical co-repressor complex containing histone deacetylase,
as well as a typical co-activator protein, histone acetyltransferase CBP/p300, leading to a
simple model in which co-activators and co-repressors might be recruited in a distinct
fashion to GATA1 activated and repressed genes, respectively. However, ChIP
experiments surprisingly revealed that chromatin occupancy of neither CBP nor NuRD
proteins distinguishes GATA1 activity since both proteins are found at active and
repressive GATA1 elements in vivo ((Grass et al., 2003; Letting et al., 2003; Martowicz
et al., 2005), and this study). This unexpected pattern of co-factor occupancy suggests
that the recruitment of these chromatin modifying/remodeling complexes is not the
pivotal determinant of transcriptional activity at GATA1 target genes. Another aspect of
GATA1-induced changes in chromatin organization, i.e. the formation of chromatin
loops occurs at both activated and repressed genes (Jing et al., 2008; Vakoc et al., 2005).
This suggests that post-translational modifications or additional GATA1-associated
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proteins might regulate the activities of co-activator and repressor proteins. We therefore
explored whether other proteins that are known to associate with GATA1 might
consistently distinguish active from repressive GATA1 complexes.
A protein complex composed of SCL, LMO2, Ldb1, and E2A can physically and
functionally associate with GATA1 (see Chapter 1.1.4). Although a few GATA-E-box
containing erythroid genes have been identified that are regulated by SCL, there are
several reasons to believe that SCL serves a broader role in transcriptional regulation in
hematopoiesis, presumably through interaction with other hematopoietic transcription
factors including GATA1. First, SCL is co-expressed with GATA1 in erythroid,
magakaryocyte, and mast cell lineages and, like GATA1, is essential for the normal
maturation of all three lineages (Hall et al., 2003; Mikkola et al., 2003; Salmon et al.,
2007). Second, DNA-binding activity of SCL is dispensable for specification of primitive
and definitive hematopoiesis, but is required for complete erythroid maturation (Kassouf
et al., 2008; Porcher et al., 1999). Strikingly, a small fraction of mice homozygous for a
DNA-binding-defective form of SCL (SCL-RER) survived to adulthood (Kassouf et al.,
2008). Third, SCL can activate transcription in the absence of an E-box through
association with other transcription factors. For example, SCL together with E47, LMO2,
and Ldb1 stimulates the promoter of the Kit cytokine receptor gene in a manner requiring
a Sp1 binding site but not an E-box or GATA element (Lecuyer et al., 2002). Moreover,
SCL and LMO2 can activate the promoter of the RALDH2 gene in T-ALL cells through
interaction with GATA3 in the absence of an E-box (Ono et al., 1998). Fourth, forced
expression of GATA1, SCL and LMO2 displayed strong synergy during induction of
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blood formation in developing Xenopus embryos (Mead et al., 2001). Fifth, it is
noteworthy that at HS2 of the β-globin LCR, a GATA site mutation reduces SCL
recruitment more strongly than does an E-box mutation (Song et al., 2007). This suggests
that GATA1 plays a critically role in the recruitment of the SCL complex even in the
absence of neighboring E-boxes.
To test a general role for the SCL complex in GATA1-dependent transcription
activation, we determined the occupancy of SCL, LMO2, E2A and Ldb1 at numerous
regulatory sites where GATA1 functions as an activator or repressor. Using an erythroid
cell line in which GATA1 can be activated conditionally (G1E-ER4, see Chapter 1.1.2),
we found that the entire SCL complex is invariably recruited to all sites where GATA1
activates transcription. In contrast, GATA1 fails to recruit the SCL complex at sites
where it functions as a repressor. Prior to gene repression by GATA1, the SCL complex
is frequently found to correlate with the presence of GATA2. The positive correlation of
the SCL complex with active GATA elements in erythroid cells was extended through
the use of ChIP-on-chip using high density tiling arrays that cover 66 megabases of
mouse chromosome 7. Moreover, SCL and GATA1 co-occupy active genes in
megakaryocytes and mast cells, further demonstrating the general nature of SCL as a
GATA1-co-activator. The co-repressor ETO-2 was absent from all GATA1/SCLactivated genes examined. Together, this work demonstrates that in contrast to several
tissue-specific or general GATA1 co-factors studied previously, the SCL complex is a
clear indicator of positive transcriptional activity of GATA1 in several hematopoietic
lineages.
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2.3: Results
2.3.1: GATA1 recruits the SCL complex to active erythroid genes
A working model for GATA1 function predicts that co-activator and co-repressor
molecules are recruited to active and repressed genes, respectively. Surprisingly, neither
the classic co-activators such as BRG1 and the histone acetyltransferase CBP (Figure 2.1)
nor the co-repressor complex NuRD (nucleosome remodeling and deacetylase) or several
other GATA1-binding factors such as FOG1 are reliable predictors of active versus
repressive transcription factors complexes (Miccio et al., 2010; Williams et al., 2004).
Since the SCL complex contains multiple subunits with transcription activating function
we examined whether it might associate selectively with GATA1-activated genes in
G1E-ER4 cells that contain an inducible version of GATA1 (see Chapter 1.1). A great
advantage of G1E-ER4 cells for this study is that genomic occupancy of GATA1 and its
co-regulators can be examined under dynamic conditions. We performed ChIP assays to
compare SCL and GATA1 occupancy at GATA1-activated genes in parental G1E cells
and G1E-ER4 cells treated with estradiol for 24 hours. The reason for choosing parental
G1E cells for comparison instead of uninduced G1E-ER4 cells is that the latter display a
certain degree of leakiness with regard to GATA1 occupancy at some sites (Johnson et
al., 2002). Increases in GATA1 occupancy were accompanied by increases in SCL
recruitment at positive acting GATA sites including HS2 and HS3 of the LCR and the
adult β-globin gene (Hbb-b1) promoter (Figure 2.2 A, B). Notably, the Hbb-b1 promoter
lacks conserved E-boxes, suggesting that SCL recruitment is mediated by GATA1
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independently of SCL DNA binding. Control experiments showed that neither GATA1
nor SCL were detected in a region approximately 1 kb upstream of the Hbb-b1
transcription site that lacks GATA sites (Figure 2.2 A, B). Moreover, SCL recruitment
was stimulated by GATA1 at additional GATA1-dependent genes, including Band3, Klf1
(EKLF), and Eraf (AHSP). These results suggest that SCL recruitment is a general
feature of GATA1 activated genes regardless of the presence of E-box elements. This
agrees with observations at regulatory regions of the Gata1 gene where SCL complexes
correlated with the presence of GATA1 even in the absence of E-boxes (ValverdeGarduno et al., 2004). In the absence of GATA1, SCL occupancy is detected at some but
not all of the examined sites (Figure 2.2 B) possibly due to the presence of E-boxes (at
Band3 and Klf1) or GATA2 which is highly expressed prior to its repression by GATA1
(Weiss et al., 1994). Indeed, when compared to controls, we found substantial enrichment
for GATA2 at HS3, Band3, Klf1, and Eraf prior to activation by GATA1 (Figure 2.2 C).
Moreover, at sites of initially high GATA2 occupancy, GATA2 was depleted upon
GATA1 activation.
Since SCL is part of a multimeric protein complex we investigated by ChIP whether
Ldb1, LMO2 and E2A follow a similar pattern. The results in Figure 2.3 show that all
three molecules are similarly enriched upon GATA1 activation. Western blots of nuclear
extracts demonstrated that protein levels of all four proteins were essentially unchanged
following GATA1-ER activation (data not shown), indicating that recruitment rather than
elevated expression accounts for the increased occupancy of the SCL complex. Thus, at
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all sites examined so far, SCL, LMO2, Ldb1 and E2A recruitment increases as a result of
increased GATA1 occupancy.
To further establish that SCL recruitment is critically determined by GATA1
occupancy, we performed time course ChIP experiments at the Hbb-b1 promoter in G1EER4 cells treated with estradiol for 4, 8, 12, 16, and 20 hours. We found that the levels of
SCL occupancy paralleled those of GATA1, suggesting that association with GATA1
rather than direct DNA binding is essential for SCL recruitment at this site (Figure 2.4).
We also investigated SCL occupancy at the α-globin locus (Hba) before and after
GATA1-ER activation, focusing on the distal regulatory sites HS-31, HS-12 and the Hbaa1 promoter. Notably, prior to GATA1 activation, high levels of SCL, E2A, Ldb1 and
LMO2 were found at HS-31 and HS-12 (Figure 2.5). In addition, low levels of the SCL
complex were detected at the Hba-a1 promoter. This generally agrees with previous
observations in which SCL and Ldb1 were found at the α-globin locus in immature cells
before the onset of transcription (Anguita et al., 2004) and could be due to the presence of
GATA2 or E-boxes or a combination of the two. Following activation of GATA1-ER, the
protein levels of SCL, E2A, Ldb1 and LMO2 decreased slightly but remained very high
when compared to other GATA1-activated genes (data not shown). This finding is
consistent with a model in which the SCL complex functions as co-activator for GATA1.
However, the function of the SCL complex at the inactive α-globin locus is unclear. It is
possible that the SCL complex is insufficient for transcription or that it actually keeps the
α-globin locus in its repressed state, perhaps via ETO-2 (Goardon et al., 2006; Meier et
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al., 2006; Schuh et al., 2005). Our ChIP experiments using antibodies against ETO-2
support the latter possibility (see below).
One observation that remains unclear is that the relative amounts of SCL and GATA1
occupancy vary. For example, at the Klf1, Eraf and Band3 genes, SCL occupancy is
higher than at the β-globin locus whereas GATA1 occupancy is somewhat higher at the
β-globin locus (Figure 2.2). Moreover, at the Hba-a1 promoter the ratio of GATA1 to
SCL is higher than at HS-31 and HS-12. It is likely that additional transcription factors or
co-factors influence SCL recruitment. Nevertheless, the SCL complex is present at all
active GATA sites examined.
To confirm these results in primary cells we performed ChIP experiments using
erythroid cells from E14.5 fetal livers. SCL, LMO2, and Ldb1 were detected at active
GATA1 target genes at levels very similar to those found in induced G1E-ER4 cells (data
not shown).
2.3.2: SCL and GATA1 co-occupy active genes in megakaryocytes and mast cells
The normal development of megakaryocytes (MK) and mast cells depends on both
GATA1 and SCL (Cantor et al., 2008; Hall et al., 2003; Migliaccio et al., 2003; Mikkola
et al., 2003; Salmon et al., 2007). To determine the relationship between GATA1 and
SCL occupancy at MK-specific promoters we performed ChIP experiments with the
murine megakaryocytic cell line L8057. Primer pairs were directed towards the proximal
promoter sequences of the early expressed αIIb and Mpl genes and the late expressed
Gplba and Pf4 genes all of which harbor well-characterized GATA elements (Szalai et
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al., 2006). We found high levels of GATA1 at the proximal promoters of GpIba and Pf4
and somewhat lower levels at the αIIb and Mpl genes (Figure 2.6 A). GATA1 was
undetectable at a control region 3 kb upstream of the αIIb transcription start site that is
devoid of GATA elements. Consistent with our findings in erythroid cells, occupancy
levels of SCL and Ldb1 correlated with that of GATA1 at megakaryocytic target genes
(Figure 2.6 A).
To examine whether the tight correlation between GATA1 and SCL proteins extends
to mast cells, we performed ChIP experiments in primary cultured bone marrow-derived
mast cells. We examined regions with known GATA binding sites near the genes
encoding the mast cell carboxypeptidase A (Mc-Cpa) (Zon et al., 1991), the mast cellspecific IgE receptor (FcεRI) β-chain (Maeda et al., 2003), the transcription factor PU.1
(Sfpi1) (Chou et al., 2009), and the Kit gene (Jing et al., 2008; Munugalavadla et al.,
2005). As expected GATA1 was present at the relevant sites but not control regions of all
four genes (Figure 2.6 B). The occupancy of SCL, Ldb1 and LMO2 followed a very
similar pattern with the regard to both spatial distribution and amount of detectable
protein (Figure 2.6 B). The -114kb region of Kit and the FcεRIβ promoter do not harbor
any E-boxes within at least 100 base pairs of the GATA elements consistent with GATA1
likely accounting for most of the SCL recruitment at these sites.
At the promoter of the Mc-Cpa gene the ratio of GATA1 to SCL proteins was lower
than that found at other sites. In contrast, this ratio was higher at the FcεRI-β promoter.
The reason for this is unclear but in contrast to mature erythroid cells, mast cells express
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high levels of GATA2 leading us to speculate that the degree of SCL recruitment might
reflect combined levels of GATA1 and GATA2.
Immunoprecipitation experiments suggested that GATA1 associates with distinct
complexes containing SCL or FOG1 but not both (Rodriguez et al., 2005). However,
FOG1 is recruited to all activating GATA sites in a manner virtually indistinguishable
from SCL proteins (Letting et al., 2004; Miccio et al., 2010; Pal et al., 2004). In trying to
reconcile these observations it is possible that the composition of GATA1-associated
protein complexes changes over time such that FOG1 is substituted by SCL or vice-versa.
While preliminary time course ChIP studies in G1E-ER4 cells do not support this model
(data not shown), very closely spaced time points might be required to reveal differences
in the kinetics of co-factor assembly. It is also possible that distinct FOG1 and SCL
containing GATA1 complexes associate in a variegated manner with alleles of the same
genes. For example, alternate/combinatorial utilization of transcription co-factors has
been described at estrogen-receptor regulated genes (Metivier et al., 2003). While
conventional ChIP experiments reflect the sum of protein interactions at all alleles,
sequential ChIP (double ChIP) experiments might address the issue of variegated protein
occupancy. Nevertheless, our results demonstrate that the SCL complex is present at all
active GATA sites examined in erythroid cells, megakaryocytes and mast cells even in
the absence of conserved E-box sequences, strongly suggesting that the SCL complex
represents a tissue-specific co-activator complex for GATA1.
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2.3.3: The SCL complex fails to assemble at GATA1-repressed genes
If the SCL complex directs positive activity of GATA1, it would be expected that it is
reduced or absent from genes where GATA1 functions as repressor. To test this
hypothesis we interrogated the occupancy of the SCL complex at genes directly repressed
by GATA1 comparing G1E cells to induced G1E-ER4 cells. We examined several
GATA elements at the Gata2 and Kit genes that were previously shown to be occupied
by GATA1 during their repression (Grass et al., 2003; Jing et al., 2008; Letting et al.,
2004; Munugalavadla et al., 2005). In induced G1E-ER4 cells, GATA1 occupied GATA
elements positioned 114kb upstream and 5kb, 58kb and 73kb downstream of the
transcription start site but not at the promoter of the Kit gene (Figure 2.7 A) in agreement
with previous results (Jing et al., 2008). Strikingly, all SCL components were depleted
from all four GATA1-occupied elements at the repressed Kit locus (Figure 2.7 A).
Similar results were obtained at the Gata2 locus where high levels of GATA1 were
associated with reduced or lost SCL occupancy 77kb and 2.8 kb upstream and 9.5kb
downstream of the transcription start site (Figure 2.7 B). Ldb1, LMO2 and E2A followed
the same trend (data not shown). At the active Kit and Gata2 loci, SCL levels correlated
well with the presence of GATA2 (Figure 2.7 A, B) (Grass et al., 2006; Jing et al., 2008),
suggesting that GATA2 might function via SCL to activate Kit and Gata2 expression in
immature erythroid cells.
Repression of Kit and Gata2 by GATA1 requires FOG1. To investigate whether
FOG1 might be required for the depletion of SCL we examined the Lyl1 gene which is
repressed directly by GATA1 in a FOG1-independent manner (Johnson et al., 2007). We
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found that SCL levels correlated inversely with GATA1 occupancy but correlated
positively with GATA2 protein levels (Figure 2.7 C). We also examined three more
GATA1-repressed genes, Etv6, Sox6 and Tram2 that contain composite GATA-E-box
elements in their regulatory regions (Wozniak et al., 2008). In the absence of GATA1 we
found high levels of GATA2 and SCL at all three promoters (Figure 2.7 D). In contrast,
upon GATA1-induced gene repression, SCL was dramatically reduced again showing
that despite the presence of conserved E-boxes in these genes, a repressive GATA1containing complex is incompatible with the presence of SCL. Together, our results show
that at all examined GATA1-dependent enhancer elements, the SCL complex co-exists
with GATA1 in erythroid cells, mast cells and megakaryocytes (Table 2.1). In contrast at
all 12 sites where GATA1 functions as a repressor, the SCL complex is reduced or absent
(Table 2.2). Despite the strong correlation between GATA1 and SCL at active genes but
not repressed genes, we cannot rule out the existence of GATA1-regulated genes where
this correlation breaks down and other factors control the overall gene activity. Future
studies spanning the entire genome will address this issue.
2.3.4: ETO-2 occupancy at GATA1-regulated genes
Since SCL is largely displaced from genes at which GATA1 represses transcription,
SCL is unlikely to play a direct role in their repression. However, at genes where SCL is
present prior to their activation, it is possible that it helps maintaining them in an inactive
state. For example, at the α-globin locus SCL has been detected prior to its transcriptional
activation (Anguita et al., 2004). The SCL complex harbors ETO-2, a member of
ETO/MTG family of corepressor proteins which can bind histone deacetylases (Goardon
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et al., 2006; Meier et al., 2006; Schuh et al., 2005). Since ETO-2 is a candidate for SCLmediated gene repression, we examined its occupancy at GATA1 target genes before and
after their activation by GATA1. We found significant levels of ETO-2 at the α-globin
gene in the absence of GATA1 which was dramatically reduced upon GATA1-ER
activation (Figure 2.8 A). Loss of ETO-2 association with the α-globin gene was not a
result of reduced ETO-2 protein levels as determined by Western blotting (data not
shown). ETO-2 was also present at other GATA1 target genes including Band3, Hbb-b1
and Klf1 prior to their activation. Notably, the amounts of ETO-2 correlated well with
GATA2 levels (compare with Figure 2.2 C). This suggests that ETO-2 might indeed
participate in repressing these genes in immature erythroid cells probably via GATA2
and SCL. Consistent with this interpretation, forced expression of ETO-2 in the erythroid
cell line MEL reduced α-globin expression, and a dominant interfering form of SCL
raised α-globin levels in erythroid progenitors (Schuh et al., 2005). However, to our
surprise, at the active Gata2 and Kit genes we also found high levels of ETO-2 which
was lost upon repression (Figure 2.8 B, C). ETO-2 levels largely mirrored those of SCL
and GATA2 (compare with Figure 2.2 A, B) except for the -77kb region of the Gata2
gene where ETO-2 levels were significantly higher than would have been predicted based
on the amounts GATA2. Thus, the ratio of ETO-2 to SCL appears to vary not only during
erythroid maturation (Goardon et al., 2006; Meier et al., 2006; Schuh et al., 2005) but
also among regulatory elements. From these data we conclude that the mere presence of
ETO-2 does not predict whether a target gene is active or repressed. This raises the
possibility that the activity of ETO-2 is regulated such that it "permits" transcription of
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certain active genes while contributing to the repression of others. Moreover, ETO-2 does
not appear to contribute to the silencing of Gata2 and Kit expression in G1E-ER4 cells
since it is removed from these genes along with the SCL core complex. Therefore, it is
surprising that expression of a dominant negative form of E2A that is defective for ETO2 binding can increase Kit expression in differentiating MEL cells (Schuh et al., 2005).
Perhaps, mature MEL cells maintain residual levels of SCL at the Kit gene to allow E2A
recruitment or the effects of mutant E2A were indirect.
2.3.5: SCL recruitment in the absence of DNA binding
Our results presented thus far support a general role for the SCL complex as a GATA
factor coactivator consistent with its ability to perform broad functions during
erythropoiesis even in the absence of direct DNA binding (Kassouf et al., 2008; Lecuyer
et al., 2002; Ono et al., 1998; Porcher et al., 1999). To evaluate the extent to which DNA
binding by SCL is dispensable for occupancy at GATA1 target genes we infected G1EER4 cells with retrovirus expressing HA-tagged SCL or a version bearing three point
mutations in the SCL basic domain that abrogates DNA binding (SCL-RER, (Porcher et
al., 1999)). Western blots showed comparable expression of HA-SCL and HA-SCL-RER
(insert in Figure 2.9 A). After 24 hours of estradiol treatment, ChIP assays were
performed with anti-HA antibodies. Wild-type SCL displayed a pattern of occupancy
resembling that of endogenous SCL with increasing occupancy at GATA1-activated
genes (Figure 2.9 A). SCL-RER occupancy was reduced at HS3, HS2, Hbb-b1 and
Band3, but occurred at virtually normal levels at the Klf1, Eraf, and Hba-a1 genes
(Figure 2.9 A). Among the genes repressed by GATA1, two sites at the Kit gene (-114 kb
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and +5kb) displayed reduced occupancy of SCL-RER while at the Gata2, Lyl1 and Rgs18
genes wild type SCL and SCL-RER were recruited similarly (Figure 2.9 B). These
results demonstrate that although direct contacts with DNA contribute to SCL occupancy,
GATA1-induced SCL recruitment can occur at numerous sites independently of DNA
binding. Since G1E-ER4 cells are definitive erythroid precursor cells, our results are also
consistent with the observation that SCL DNA binding is required for normal definitive
erythropoiesis (Kassouf et al., 2008; Porcher et al., 1999). Based on previous work
(Porcher et al., 1999) it is predicted that in primitive erythroid cells GATA1 or perhaps
additional transcription factors might be entirely sufficient for tethering the SCL complex
to its target genes.
2.3.6: Widespread association of GATA1 with SCL at enhancers
To examine the generality of the association between GATA1 and SCL, we
investigated the co-occupancy of DNA segments by GATA1 and the SCL complex over
a 66Mb region of mouse chromosome 7. ChIP was performed with antibodies against
SCL and Ldb1 in G1E-ER4 cells treated with estradiol for 24 hours and parental G1E
cells lacking GATA1. ChIP material was amplified and hybridized to high density
NimbleGen custom arrays spanning 66Mb of chromosome 7. Data were analyzed and
compared to GATA1 ChIP (Cheng et al., 2008). The peak-calling program Tamalpais
(Bieda et al., 2006) identified 97 GATA1-bound sites in estradiol-treated G1E-ER4 cells
within regions containing few repetitive sequences ("chipable regions") (Table 2.3 A). 63
DNA segments were unequivocally found to be occupied by GATA1 as confirmed by
quantitative PCR (Cheng et al., 2008). Hybridization with SCL and Ldb1 ChIP DNA
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revealed a strikingly similar pattern of occupancy for these two proteins. Overall, the
signal intensity for SCL was highly correlated with that for Ldb1 (r = 0.66), and 86% of
the SCL peaks overlap with Ldb1 peaks. This suggests that in the majority of cases Ldb1
and SCL are associated.
SCL and Ldb1 proteins also showed a strong tendency for co-occupancy with
GATA1. Of the 63 DNA segments validated as occupied by GATA1, 48 (76%) were also
positive for SCL and Ldb1 occupancy. Almost all of these are associated with enhancer
activity (see below). Also, considering individual probes in the 63 GATA1-occupied
DNA segments, the hybridization signals between SCL and Ldb1 ChIPs are tightly
correlated (r= 0.93), even higher than the correlation for the entire 66Mb target region.
This higher correlation suggests that all three proteins, GATA1, SCL and Ldb1, tend to
bind DNA in a complex.
We identified 247 SCL-occupied sites (Table 2.3 A), which exceeded the number of
GATA1 peaks. Although the great majority of the validated GATA1-occupied DNA
segments were co-occupied by SCL and Ldb1, only 20% of the SCL-occupied segments
are co-occupied by GATA1. This is consistent with SCL having functions that are
independent of GATA1.
We next examined whether the DNA segments co-occupied by GATA1, SCL, and
Ldb1 are active enhancers in vivo. 61 of the 63 GATA1-bound DNA segments were
added to a luciferase expression plasmid with a HBG1 gene promoter and transfected into
K562 cells. Based on their activities, the DNA segments were partitioned into a group of
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27 that have enhancer activity (increased luciferase activity more than 2-fold compared to
the parental plasmid), a group of 21 with no positive activity (less than 1.5-fold effect),
and a group of 13 with threshold activities (1.5 to 2-fold effects). All but one of the active
enhancers were also occupied by SCL and Ldb1 by the ChIP-on-chip data (Figure 2.10).
The sole exception (activity indicated by the gray box) was in a repeat-rich region that is
problematic for ChIP-on-chip analysis, and indeed we found that it also was occupied by
SCL and Ldb1 by quantitative PCR (data not shown). Thus, all GATA1-occupied DNA
segments with enhancer activity were associated with SCL and Ldb1. In contrast, the
GATA1-bound DNA segments with no positive activity were co-occupied by SCL and
Ldb1 much less frequently (10 out of 21). The correlation of co-occupancy with enhancer
activity was highly significant (p-value = 1.5x10-5 by Fisher’s Exact Test).
Another important conclusion is that a GATA element (WGATAR) is a better
predictor of SCL occupancy than is the E-box (CANNTG). We measured the enrichment
of motifs in bound segments as the proportion of protein-bound DNA segments that
contain a specified motif divided by the proportion of background DNA segments that
contain the same motif. The segments occupied by SCL showed very little enrichment for
the E-box (1.03) but substantial enrichment for the GATA element (1.25) (Table 2.3 A).
A notable result is that an E-box might not be essential for SCL recruitment. Of the
48 sites co-occupied by GATA1, SCL, and Ldb1, 47 had a perfect WGATAR motif, as
expected, but only 25 had an E-box within 20 base pairs of the GATA element (Table 2.3
B). This suggests that at the remaining sites, SCL recruitment occurred via GATA1 and
not via direct DNA binding of SCL. However, given the frequent occurrence of E-boxes
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it remains impossible to discern whether E-boxes that reside further away from the
GATA1 bound site contribute to SCL recruitment. Nevertheless, our observation of the
highly dynamic nature of SCL recruitment in response to changes in GATA factor
occupancy (Figure 2.2) is consistent with a model in which levels of SCL recruitment are
controlled by GATA1 at GATA1-occupied sites.
Many of the elements occupied by GATA1 and/or SCL are found at substantial
distances from the nearest genes making it difficult to assess which of these genes if any
they control. However, it is notable that 27 of 48 elements occupied by GATA1, SCL
and Ldb1 reside closer to activated genes than to repressed genes. Conversely, the
majority of elements (11 of 15) occupied solely by GATA1 are found closer to genes that
are repressed. Together the above results are consistent with the notion that the SCL
complex functions as co-factor for GATA1 during activation but not repression of
transcription.
2.3.7: LMO2 is required for activation but not repression of GATA1-dependent genes
The selective presence of the SCL complex at active GATA1-bound regions is
consistent with its role as a co-activator. Consequently, loss of SCL or its associated
proteins is expected to impair GATA1-mediated activation but not repression. To test this
prediction, we knocked down LMO2 which bridges GATA1 and the SCL complex. An
LMO2 shRNA was introduced

into G1E-ER4 cells with the retroviral vector

pMSCV/LTRmiR30-PIG containing GFP. Since we observed significant cell death upon
infection, we used a derivative of G1E-ER4 cells expressing the anti-apoptotic protein
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Bcl-XL, which improved viability (Welch et al., 2004). FACS was employed to generate
pools of GFP-positive cells. LMO2 expression was diminished as determined by Western
blotting (Figure 2.11 A). SCL levels were unaffected by the LMO2 knock down (data not
shown). Cells were treated with estradiol or were left untreated for 24 hours, and mRNA
levels of GATA1-activated and repressed genes were analyzed by quantitative RT-PCR
using GAPDH as internal standard. We observed a 47% and 36% reduction in the foldincrease of Hbb-b1 and Eraf, respectively in the LMO2 knockdown cells when compared
to controls (Figure 2. 11 B). In contrast, the LMO2 knockdown did not diminish the
GATA1-induced repression of the Kit, Gata2 and Lyl1 genes (Figure 2. 11 C). In the case
of Gata2, the fold-repression was even increased from 17-fold in control cells to 26-fold
in the LMO2 knockdown cells. These results are consistent with the SCL complex
serving selectively as coactivator but not co-repressor of GATA1. There was a trend in
LMO2 knockdown cells towards a slight reduction in the expression of the Kit, Gata2
and Lyl1 genes prior to their repression by GATA1, although the results are not
statistically significant (data not shown). This might reflect a requirement of SCL for the
expression of these genes through interaction with GATA2.
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2.4: Discussion
Here, we demonstrated that SCL and associated proteins function as a tissue-specific
GATA1-coactivator complex that is present at activating but not repressive GATA1bound regulatory elements. The SCL complex can be recruited to chromatin via its
interaction with GATA1 in the absence of E-boxes, and is specifically required for
GATA1 mediated gene activation but not repression. Our work identified the SCL
complex as a critical and consistent determinant of positive GATA1 activity in multiple
GATA1-regulated hematopoietic cell lineages. These observations have been further
confirmed with ChIP-seq data sets in our later studies (Cheng et al., 2009).
The next challenge will be to determine what mechanism accounts for the selective
presence of SCL proteins at active GATA elements. It is possible that selectivity is
achieved at the level of recruitment. How such specificity would be achieved is unclear
but might involve posttranslational modifications of GATA1. Alternatively, the SCL
complex might be recruited to both active and repressed GATA1-bound genes but
removed selectively at sites where GATA1 represses transcription. This might involve
proteasome-mediated turnover of LMO2 or Ldb1 (Ostendorff et al., 2002; Xu et al.,
2007). Indeed, treatment of G1E-ER4 cells with the proteasome-inhibitors MG132 or
lactacystein blocks removal of SCL from the Kit and Gata2 genes during GATA1induced repression (data not shown). However, since the proteasome is also required for
the exchange of GATA1 for GATA2 (Lurie et al., 2008; Minegishi et al., 2005) further
work is needed to assess the role, if any, of proteasome-mediated turnover of the SCL
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complex at GATA1-repressed genes. One prediction from our results is that forced
constitutive interaction between SCL and GATA1 might impair the ability of GATA1 to
function as transcriptional repressor. To test this idea, we fused GATA1 in frame to SCL
or LMO2 and introduced fusion constructs into G1E cells via retroviral transduction. We
found that the GATA1-SCL and GATA1-LMO2 fusion proteins functioned almost
indistinguishably from wild-type GATA1 with regard to both activating and repressive
functions (data not shown). This result might be explained if one or more components of
the SCL complex are proteolyzed at repressed elements thus allowing repression to
proceed unimpaired.
If the presence of the SCL complex specifies activating GATA1, are there tissuespecific or general GATA1 co-factors that consistently specify repression by GATA1?
As discussed above, neither the presence of FOG1 nor NuRD are diagnostic for
repressive GATA1 complexes as they are also found at GATA1-activated genes.
Candidate GATA1-co-repressor proteins include Gfi-1b which can physically associate
with GATA1. However Gfi-1b is detected only at a subset of GATA1-repressed genes
(Rodriguez et al., 2005). Gfi-1b also binds to SCL presumably via ETO-2 but its
functional role within this complex remains unknown (Schuh et al., 2005). PU.1 directly
binds to GATA1 and is thought to antagonize its activity in progenitor cells to inhibit
erythroid development (Nerlov et al., 2000; Rekhtman et al., 1999; Zhang et al., 1999).
However, PU.1 expression is extinguished during erythroid differentiation and might not
function during the repression of GATA1-dependent genes in late maturing erythroid
cells. Considering the available evidence it is possible that repression by GATA1
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involves distinct co-repressor molecules depending on the cell lineage, promoter context,
and maturation stage.
An important question remains as to how SCL augments GATA1 transcriptional
activity. SCL associates with histone acetyltransferases p300 and P/CAF and is itself
acetylated, similar to GATA1 (Blobel et al., 1998; Huang et al., 2000; Huang et al., 1999;
Hung et al., 1999). Increasing the levels of p300 and/or P/CAF might increase the ratio of
histone acetylases to deacetylases to facilitate transcriptional activation. However, we and
others have found that the p300 paralog CBP remains associated with some GATA1repressed genes. Whether the same is true for P/CAF and p300 remains to be examined.
Another possibility is that SCL association with GATA1 governs the specific activity or
substrate recognition of chromatin remodeling/modifying enzymes. An example for this
possibility was provided by studies of the hematopoietic transcription factor NF-E2
which enhanced the nucleosome directed acetyltransferase activity of CBP (Chen et al.,
2001). The SCL complex co-localizes with GATA1 on chromatin at many putative
intergenic enhancer elements as well as the TSS (this study and (Cheng et al., 2009)),
therefore it is possible that SCL and associated proteins function by promoting enhancerpromoter communication (see Chapter 3). In any case, the SCL complex fulfills the
criteria of a bona-fide coactivator in that it can stimulate GATA1 activity and is
associated with most if not all active but not repressive GATA factor complexes in vivo.
2.5: Figures
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Figure 2.1
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Figure 2.1. CBP levels at GATA-1 regulated genes. ChIP analysis with CBP
antibodies or isotype-matched control antibodies (IgG) of the indicated sites at the βglobin (Hbb-b1) locus (top panel), the Kit (middle panel) and Gata2 (bottom panel)
genes. ChIP experiments were performed in G1E cells and G1E-ER4 cells after E2
treatment for 21-24h. The data shown are the averages of two independent experiments.
Error bars represent standard deviations.
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Figure 2.2
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Figure 2.2. GATA1 recruits SCL to active erythroid genes.
ChIP analysis using GATA1 (A), SCL (B) and GATA2 (C) antibodies or isotype
matched control antibodies (IgG) and primers for indicated sites. Primers for 1 kb
upstream of the Hbb-b1 promoter (-1 kb) served as negative control. ChIP experiments
were performed in G1E cells (-GATA1) and G1E-ER4 cells after E2 treatment for 2124h (+GATA1). The data are the averages of three or more independent experiments.
Error bars represent standard deviations.
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Figure 2.3
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Figure 2.3. Co-occupancy of Ldb1, LMO2 and E2A at GATA1-activated genes.
ChIP analysis using Ldb-1, LMO2 and E2A antibodies. Experiments were performed in
G1E cells and G1E-ER4 cells after E2 treatment for 21-24h. The data are the averages of
three or more independent experiments. Error bars represent standard deviations.
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Figure 2.4

Figure 2.4. Time course ChIP of GATA1 and SCL. Anti-GATA-1 and anti-SCL
antibodies were used to perform ChIP in G1E-ER4 cells at indicated time points
following treatment with estradiol. Primer pairs were directed against the Hbb-b1
promoter or as control a region 1 kb upstream. The data shown are the averages of two
independent experiments. Error bars represent standard deviations.
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Figure 2.5
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Figure 2.5. Association of the SCL complex with the α-globin (Hba) locus. ChIP
analysis using GATA-1, GATA-2, SCL, Ldb-1, LMO2 and E2A antibodies or isotypematched control antibodies. ChIP experiments were done in G1E cells and G1E-ER4
cells after E2 treatment for 21-24h. The data shown are the averages of three or more
independent experiments. Error bars represent standard deviations.
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Figure 2.6
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Figure 2.6
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Figure 2.6. GATA1, SCL and Ldb1 co-occupy active genes in megakaryocytes
and mast cells. ChIP analysis using GATA1, SCL, Ldb1, or isotype-matched control
antibodies in megakaryocytic L8057 cells (A) and primary bone marrow derived mast
cells (B). The -3 kb region upstream of αIIb served as negative control. The data shown
are the averages of three or more independent experiments in (A) and two independent
experiments in (B). Error bars represent standard deviations.
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Figure 2.7

58

Figure 2.7
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Figure 2.7
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Figure 2.7. Depletion of SCL from GATA1 repressed genes. ChIP analysis using
GATA1, SCL, GATA2, or isotype matched control antibodies at Kit (A), Gata2 (B), the
FOG-1-independent Lyl1 gene (C), and the GATA-E-box containing genes Etv6, Sox6,
and Tram2 (D). ChIP experiments were performed as in Figure 1. The data are the
averages of three or more independent experiments. Error bars represent standard
deviations. Please note that the difference in absolute signal intensity for the SCL ChIP
between panels C and the other panels is due to the use of a different batch of SCL
antibodies.
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Figure 2.8
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Figure 2.8. ETO-2 occupancy at GATA1-regulated genes. ChIP analysis using
ETO-2 or isotype matched control antibodies at indicated GATA1-activated (A) and
repressed Kit (B) and Gata2 (C) genes. Prom, promoter. ChIP experiments were
performed as in Figure 1. The data are the averages of three or more independent
experiments. Error bars represent standard deviations.
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Figure 2.9
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Figure 2.9

Figure 2.9. SCL recruitment in the absence of DNA binding. Anti-HA or control
IgG ChIP of GATA1-activated (A) and repressed (B) genes in G1E-ER4 cells expressing
HA-tagged SCL (HA-SCL) or HA-SCL-RER (HA-SCL*), before and after estradiol (E2)
treatment for 21-24h. The data shown are the averages of two (Klf1, Gata2 -2.8), three
(HS3, Hba-a1, -31, Hba-a1 promoter, Lyl1 and Rgs18 promoters) and four (HS2, Hbbb1, Hbb-b1 promoter, Band3, Band3 promoter, Kit -114, Kit +5) independent
experiments. Error bars represent standard deviations.
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Figure 2.10
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Figure 2.10. Erythroid enhancers are co-occupied by GATA1, SCL, and Ldb1.
61 DNA segments occupied in vivo by GATA1 whose enhancer activities were
determined in (Cheng et al., 2008) were evaluated for co-occupancy by SCL and Ldb1,
based on the ChIP-on-chip results. The distribution of results after transient transfection
of K562 cells (range of 8 to 24 determinations for each GATA1-occupied DNA segment)
is shown as a box-plot, with the internal line indicating the median, the box extending to
the first and third quartiles, and the whiskers extending to the most extreme data point
that is no more than 1.5 times the interquartile range. Black boxes represent DNA
segments co-occupied by GATA1, SCL and Ldb1; white boxes represent sequences that
are only occupied by GATA1. The gray box shows results for a DNA segment that was
not called as an SCL peak in ChIP-on-chip but was shown by qPCR to be occupied by
SCL. The horizontal line is the threshold for determining a DNA fragment as an
enhancer. The results were partitioned into the DNA segments with clear enhancer
activity, those clustered around the threshold, and those with no positive effect.
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Figure 2.11

Figure 2.11. LMO2 is required for activation but not repression of GATA1regulated genes (A) anti-LMO2 Western blot of nuclear extracts from Bcl-XLexpressing G1E-ER4 cells transduced with vector producing an shRNA against LMO2 or
empty vector (ctr). β-actin served as loading control. (B, C) Cells were treated with
estradiol (E2) for 24 hours and mRNA levels of indicated genes were determined by realtime RT-PCR. Results were normalized to Gapdh mRNA and plotted as fold-change
when compared to untreated cells. The data are the averages of 4 independent
experiments. Error bars represent standard deviation.
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Table 2.1 GATA1-activated genes
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Table 2.2 GATA1-repressed genes
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Table 2.3 Analysis of ChIP-on-chip data
(A)
Occupied by a :
Total in SCL Enrichmentc pGATA- Enrichment pchipable
valueb 1
value
region
Number of
DNA
segments

51,079

247

97

Number of DNA segments with motif:
WGATAR

36,672

222

1.252

0

90

1.292

0

CANNTG

48,463

242

1.033

0.005

91

0.989 0.624

Number of DNA segments with motif within 20 bp of WGATAR:
CANNTG

13,246

107

1.67

71

0

44

1.749

0

(B)
Occupied by a :
Total in GATA- Enrichment pGATA- Enrichment pchipable 1, SCL,
value 1 alone
value
region Ldb1
Number of
DNA
segments

51,079

48

15

Number of DNA segments with motif:
WGATAR

36,672

47

1.364

0

15

1.393

0

CANNTG

48,463

47

1.032 0.086

15

1.054

0

Number of DNA segments with motif within 20 bp of WGATAR:
CANNTG

a

13,246

25

2.008

0

5

1.285 0.163

DNA segments occupied by SCL were determined as the central 600 bp of the peaks

identified by the program Tamalpais, using the most stringent (L1) threshold. DNA
segments occupied by GATA-1 were determined by the program Tamalpais, using the L3
threshold.
b

The p-value was determined empirically; it is the number of times (out of 1000

repetitions) that the fraction of a randomly chosen set of intervals that contains a match to
the designated motif exceeds that observed for the set of occupied DNA segments. The
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intervals for comparison were randomly selected from the "chipable" region of the 66Mb
region of chromosome 7. The chipable portion of the 66Mb region is the part that is
interrogated by hybridization to the high-density tiling array. The "chipable" region is
repeat-poor (>500 bp without a repeat) and comprises approximately 30647 kilobases.
c

Enrichment is defined as the proportion of protein-bound DNA segments that contain

a specified motif divided by the proportion of background DNA segments that contain
the same motif.
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CHAPTER 3: Controlling Long-range Genomic
Interactions at a Native Locus

Research presented in this chapter was carried out in collaboration with the Ann Dean
laboratory and Sangamo BioSciences, Inc. Pregnant ΔLCR mice were prepared by
Jongjoo Lee from the Ann Dean laboratory, and artificial zinc finger proteins were
designed and optimized in collaboration with Andreas Reik, Jeff Miller and Philip
Gregory from Sangamo BioSciences. Hongxin Wang provided technical assistance.
This research was originally published in Cell. Wulan Deng, Jongjoo Lee, Hongxin
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3.1: Chapter Summary
Distal enhancers can activate genes over a long genomic distance. They are found to
be physically linked with active promoters and therefore chromatin fibers form loop
structures. However, the molecular architecture of chromatin loops and the cause-effect
relationship with transcription activation remain unclear. In erythroid cells, the LCR and
β-globin promoter form a chromatin loop that requires transcription factor GATA1 and
Ldb1 (Song et al., 2007; Vakoc et al., 2005). From our studies presented in Chapter 2, we
observed that the Ldb1-containing SCL complex binds numerous putative enhancer
elements and active promoters that are co-occupied by GATA1, suggesting a general role
of Ldb1 in promoting GATA1-regulated enhancer-promoter interaction. Here we tested
whether artificial tethering of Ldb1 to the endogenous β-globin promoter can substitute
for GATA1 function in chromatin looping and transcription activation. We employed
artificial zinc fingers (ZF) to tether Ldb1 to the β-globin promoter in GATA1 null
erythroblasts in which the β-globin locus is relaxed and inactive. In vivo binding of the
ZF-Ldb1 to its target was verified by ChIP assays. Remarkably, targeting Ldb1 or only its
self-association domain to the β-globin promoter substantially activated β-globin
transcription in the absence of GATA1. Chromosome conformation capture (3C)
experiments showed that expression of ZF-Ldb1 constructs triggered physical association
between the LCR and the β-globin promoter via interaction with endogenous Ldb1
complexes at the LCR. ZF-Ldb1 expression induced two additional LCR-dependent
functions, Pol II recruitment and serine 5 phosphorylation, further supporting the idea
that ZF-Ldb1 induced a functional LCR-β-globin promoter chromatin loop. Expression of
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ZF-Ldb1 constructs in primary erythroid precursor cells from mice heterozygous for a
deletion of the LCR followed by allele-specific qPCR demonstrated that the activation of
β-globin expression was indeed due to long-range LCR-β-globin promoter interactions
and not to secondary effects of ZF-Ldb1 expression. In concert, our findings establish
Ldb1 as a critical effector of GATA1-mediated loop formation and indicate that
chromatin looping causally underlies cellular gene regulation. In broader terms, this work
suggests that forced chromatin looping can be employed to regulate the expression of
endogenous genes.
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3.2: Introduction
Gene activity is controlled by a combination of proximal and distal regulatory
elements that can be separated by up to hundreds of kilobases. Longstanding questions
have been how these elements interact functionally to regulate gene expression, how gene
specificity is achieved, and how unwanted effects on nearby irrelevant genes are avoided.
The use of chromosome conformation capture (3C) and its derivatives has revealed that
distant chromosomal elements can be juxtaposed to form chromatin loops, thus providing
one mechanism of long-range enhancer function (Cullen et al., 1993; Dekker et al.,
2002). Chromatin looping has been discovered at numerous gene loci, and reflects a
widespread organizing principle of the chromatin fiber (Dean, 2011; Kadauke and
Blobel, 2009; Miele and Dekker, 2008; Schoenfelder et al., 2010a; Sexton et al., 2009).
Although looping can occur at genes prior to their full activation, the onset of
transcription is tightly associated with additional looped interactions (Palstra et al., 2003;
Spilianakis and Flavell, 2004; Vernimmen et al., 2007). However, based on studies using
pharmacological inhibitors of transcription elongation, it has become clear that ongoing
transcription is dispensable for sustaining preformed chromatin loops (Mitchell and
Fraser, 2008; Palstra et al., 2008b). Moreover, chromatin looping is not limited to active
genes. For example, upon repression of the Kit gene, loss of an enhancer-promoter loop
is accompanied by de novo loop formation within the gene body (Jing et al., 2008). These
studies indicate that chromatin loops are highly dynamic and occur at active and
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repressed genes but leave open the question as to whether these long-range interactions
are a cause or consequence of dynamic changes in transcription initiation.
The molecular mechanisms that establish and maintain chromatin loops remain
incompletely understood. Fundamental insights into these issues arose from studies of the
mammalian β-globin locus, which is among the first gene clusters at which long-range
chromosomal interactions between a powerful distal enhancer, the locus control region
(LCR), and the target β-globin promoters were described (Carter et al., 2002; Tolhuis et
al., 2002). Mechanistic studies defined gene-specific transcription factors that establish
LCR-β-globin interactions, including the hematopoietic-restricted factors GATA1 and its
co-factor FOG1 (Vakoc et al., 2005), KLF1 (Drissen et al., 2004), and the more broadly
expressed protein Ldb1 (Song et al., 2007). Functional disruption of any of these factors
was associated with reduced LCR-β-globin interactions and diminished β-globin
transcription. However, physical interactions among all of these proteins have been
reported (Cantor and Orkin, 2002), making it difficult to distinguish whether they
function in linear or parallel pathways. Moreover, whether loss of looping underlies the
loss of transcription or vice versa remains an open question in these studies.
GATA elements are present at the β-globin promoter and LCR, suggesting that
GATA1 and its co-factors are involved in the juxtaposition of these sites. Restoring
GATA1 activity in the GATA1 null proerythroblast cell line G1E leads to an GATA1dependent activation of β-globin gene transcription with concomitant LCR-β-globin
looping (Vakoc et al., 2005). The transcription co-factor Ldb1 (also called NLI) does not
bind DNA directly but is recruited to E-box elements or GATA elements via a multi78

component complex that includes the TAL1, LMO2, E2A and GATA1 (see Chapter 1.1).
Chapter 2 and subsequent studies show that GATA1 and Ldb1 display a highly
overlapping genomic occupancy pattern but notably, Ldb1 association strongly favors
sites at which GATA1 functions as a transcriptional activator, such as the β-globin locus
(Cheng et al., 2009; Kassouf et al., 2010; Soler et al., 2010; Tripic et al., 2009; Wu et al.,
2011). Several observations suggest that Ldb1 might be a critical effector of GATA1’s
looping function. First, knockdown of Ldb1 impairs LCR-β-globin looping (Song et al.,
2007). Second, the Drosophila homolog of Ldb1, Chip, is required for long-range
enhancer action (Morcillo et al., 1997). Third, like GATA1, Ldb1 co-occupies the βglobin promoter and LCR and might therefore function by physically linking the two
(Song et al., 2007; Tripic et al., 2009). Fourth, Ldb1 can form homodimers and even
higher order oligomers (Cross et al., 2010; Jurata and Gill, 1997), which might underlie
its role in loop formation.
Numerous studies indicate that chromatin loops are highly dynamic and associated
with transcription change. However, these studies are descriptive of correlations by
nature, and leave open the question as to whether these long-range interactions are a
cause or consequence of dynamic changes in transcription initiation. Prior studies in
prokaryotes (for review see (Marenduzzo et al., 2007)) as well as in eukaryotic cells
using plasmid constructs have succeeded in influencing gene expression through forced
looping among regulatory elements (Ameres et al., 2005; Mahmoudi et al., 2002; Nolis et
al., 2009; Petrascheck et al., 2005). However, the use of plasmids with altered chromatin
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configuration and the relatively short genomic distances might limit inferences with
regard to long-range chromatin interactions at native gene loci.
Here we devised a strategy to modulate chromatin looping at an endogenous locus in
its native environment. This enabled us to address whether forced chromatin looping can
activate transcription, to examine the hierarchy of transcriptional regulators in chromatin
looping, and to define the ensuing molecular and functional consequences. For our
studies we used G1E erythroid cells since they lack transcription factor GATA1 and thus
fail to establish an LCR-β-globin loop and transcribe β-globin. Ldb1 recruitment to the βglobin promoter is entirely GATA1 dependent, whereas substantial amounts of the
Tal1/Ldb1 complex remain associated with LCR in the absence of GATA1 (Figure 2.2
and 2.3 of Chapter 2 and Figure 3.1 A). Therefore, Ldb1 recruitment by GATA1 to the
promoter might represent a critical rate-limiting step in juxtaposing the LCR with the
promoter to form a loop required for transcription initiation (Figure 3.2 A). We tested
this hypothesis by using a zinc finger (ZF) targeting approach to tether Ldb1 to the βglobin promoter in G1E cells (Figure 3.2 A). Notably, promoter bound ZF-Ldb1 was
capable of inducing a chromatin loop in G1E cells to an extent similar to that achieved by
GATA1 restoration. ZF-Ldb1 constructs completely restored RNA polymerase II (Pol II)
recruitment and Pol II serine 5 phosphorylation (Ser5ph), and partially rescued β-globin
transcription. Genetic experiments in erythroid cells heterozygous for a deletion of the
LCR confirmed that the ZF-Ldb1 proteins functioned via a long-range looping
mechanism. These results reveal that forced juxtaposition of regulatory regions can
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activate transcription and establish Ldb1 as a critical rate-limiting effector of GATA1
during chromatin looping.

3.3: Results
3.3.1: Zinc finger-mediated targeting of Ldb1 to the endogenous β-globin locus
As a strategy to tether potential looping factors to the endogenous β-globin locus we
chose artificial zinc finger proteins (ZF) since they have been used successfully to target
preselected genomic sites in vivo (for review see (Klug, 2010)). ZFs were synthesized to
target the β-major promoter (P-ZF) and DNase1 hypersensitive site 2 (HS2) of the LCR
(L-ZF) (Figure 3.1 B) as these sites were previously found to be in close physical
proximity (Carter et al., 2002; Tolhuis et al., 2002). Six zinc fingers were linked in
tandem to target 18 base pairs of genomic sequence (for review see (Klug, 2010)). Target
sequences were chosen within the DNase I hypersensitive regions to facilitate access to
the ZFs but avoid interference with known transcription factor binding sites (Figure 3.1
B). Binding of the ZFs to their designated DNA sequences was characterized using a
previously described ELISA-based assay (data not shown) (Bartsevich et al., 2003). ZFs
were fused to an HA tag and a nuclear localization sequence (NLS), and their chromatin
binding profiles were examined by chromatin immunoprecipitation (ChIP) following
introduction into G1E cells (Figures 3.1 C, D and data not shown). ZFs with suitable
binding properties were fused to Ldb1, and introduced into a retroviral vector containing
an IRES-GFP or IRES-YFP cassette. Upon infection of G1E cells, populations of
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GFP/YFP positive cells were purified by fluorescence activated cell sorting (FACS) and
subjected to anti-HA ChIP. We identified a P-ZF that strongly bound the β-globin
promoter in G1E cells (Figure 3.1 C). Fusion of Ldb1 with P-ZF (P-Ldb1) retained strong
binding to the β-globin promoter but was also detectable at low levels at multiple HSs of
the LCR (Figure 3.2 B). In the absence of the Ldb1 moiety, this ZF bound to these LCR
sites with lower efficiency (Figure 3.1 C), indicating that the association of P-Ldb1 with
the LCR is in large part due to its interaction with endogenous Ldb1 complexes at the
LCR (Tripic et al., 2009). In addition, L-Ldb1 (L-ZF fused to Ldb1) was found to bind to
HS2 but not the β-globin promoter (Figure 3.2 C), consistent with the lack of endogenous
Ldb1 complexes in the absence of GATA1 (Figure 3.1 A). Finally, cells co-expressing LLdb1 and P-Ldb1 produced comparable ChIP signals at the LCR and β-major promoter
(Figure 3.2 D).
It is noteworthy that ChIP results comparing several ZF proteins in erythroblasts and
fibroblasts (not shown) revealed that the binding properties of ZFs to naked DNA
sequences in vitro do not fully predict their binding efficiency in vivo. Nevertheless, we
were able to identify a ZF pair capable of targeting Ldb1 to the β-globin locus.
3.3.2: Tethering Ldb1 to the β-globin locus activates transcription in the absence of
GATA1
LCR-promoter looping is required for high-level globin gene expression throughout
erythroid development. Therefore, we examined whether promoter- and/or LCR-tethered
Ldb1 induces β-globin transcription in G1E cells. Since G1E cells lack GATA1, the β82

globin promoter is devoid of Ldb1 whereas the LCR retains significant amounts of Ldb1
mediated by the TAL1 complex bound to E-box elements (Figures 3.1 A). Remarkably,
expression of P-Ldb1 activated β-globin transcription over a thousand-fold (Figure 3.3 A)
amounting to approximately 20% of that achieved upon restoration of GATA1 (G1E-ER4
cells) (Figure 3.3 B). L-Ldb1 alone or ZFs without the Ldb1 moiety displayed little
activity (Figure 3.3 A). Co-expression of P-Ldb1 and L-Ldb1 failed to further activate βglobin expression compared to P-Ldb1 by itself (Figure 3.3 A). Because high level βglobin expression requires the LCR (Bender et al., 2000), these results suggest that
promoter-bound Ldb1 is sufficient to promote long-range contacts with at the LCR,
presumably via endogenous Ldb1, to activate transcription (see below). Measurements of
β-globin expression were confirmed with multiple primer pairs directed against the βglobin transcript (Figure 3.3 C). Moreover, the effects of ZF-Ldb1 expression were genespecific and not simply a consequence of a general differentiation induction since the
expression of several additional GATA1 activated (Klf1, Eraf, bH1) and repressed
(Gata2, Kit) genes was unchanged (Figure 3.3 D, and data not shown). The potent
activation by ZF-Ldb1 fusion proteins of β-globin transcription is particularly remarkable
since it occurred in the absence of GATA1, which is essential for β-globin transcription.
The substantial β-globin transcriptional activation by ZF-Ldb1 strongly implicates an
LCR looping mechanism since β-globin transcription is reduced to ~1% of normal when
the LCR is deleted (Bender et al., 2000). Moreover, Ldb1 occupancy at the β-globin
promoter is normal in the absence of the LCR (Song et al., 2010), indicating that
promoter-bound Ldb1 alone is insufficient for β-globin transcription without the LCR.
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Although β-globin activation by ZF-Ldb1 fusion proteins was substantial, their effects
did not match those of GATA1, consistent with GATA1 exerting functions in addition to
chromatin looping.
3.3.3: Tethering of the Ldb1 self-association domain is sufficient for β-globin activation
Ldb1 contains an N-terminal self-association (SA) domain that mediates the assembly
of higher order molecular complexes and might account for its looping function (Cross et
al., 2010; Xu et al., 2003), and a C-terminal LIM interaction domain (LID) that confers
binding to LMO2 and its associated GATA1/TAL1/E2A multi-protein complex. To
examine whether the SA domain is sufficient for transcription activation, it was fused
with L-ZF and P-ZF and introduced into G1E cells. P-SA and L-SA showed very similar
genomic binding profiles as the full-length Ldb1 fusion constructs such that L-SA
occupied HS2 whereas P-SA bound the β-globin promoter and additionally the LCR
(Figure 3.4 A). Remarkably, expression of P-SA alone or co-expression of L-SA and PSA activated β-globin gene transcription to virtually the same level as did the full-length
Ldb1 fusion proteins (compare Figures 3.4B with Figure 3.3A). Again, the effects of ZFSA were gene-specific and did not globally alter erythroid gene expression (Figure 3.4C).
These results suggest that the Ldb1 self-association domain is sufficient to induce βglobin transcription, further supporting the idea that forced juxtaposition between the
LCR and β-globin promoter underlies transcriptional activation.
We also considered the possibility that the remaining portions of Ldb1 might
participate in chromatin looping by nucleating higher order protein complexes. To this
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end we generated a ZF-Ldb1 fusion protein lacking the SA domain (P-∆SA) but leaving
the nuclear localization sequence and LID domain intact. P-∆SA was capable of inducing
β-globin transcription albeit to a significantly lower degree than P-SA (Figure 3.4D).
Activation never exceeded 50% of that observed with P-SA even under the most optimal
conditions and expression levels (Figure 3.4D and data not shown). This supports the
idea that the SA domain is most efficient in nucleating higher order complexes required
for looping. Nevertheless, these results are also consistent with the possibility that Ldb1
can engage its partner proteins via distinct domains to produce chromatin loops.
3.3.4: Tethering of the Ldb1 self-association domain induces LCR-promoter looping
The strong induction of β-globin transcription by ZF-Ldb1 or ZF-SA implicates an
involvement of the LCR and hence chromatin looping, since in the absence of the LCR βglobin transcription is very low (Bender et al., 2000). Therefore, we examined by 3C
assay whether expression of ZF-SA constructs juxtaposed the LCR with the β-globin
gene to form a chromatin loop (for 3C assay optimization, see Chapter 3.6). Using HS2
as the anchor region we found that in parental G1E cells the 3C signals generally
declined with increasing distance (Figure 3.5A), consistent with our previous
observations (Vakoc et al., 2005). In particular, there is no interaction between HS2 and
β-globin. Upon GATA1 restoration, the relative proximity of HS2 with two adjacent
fragments comprising the β-major globin gene significantly increased (Figure 3.5A). HS2
interactions with intervening or downstream segments remained low, indicative of a
GATA1-dependent HS2-β-globin chromatin loop (Vakoc et al., 2005). We next
determined the chromatin conformation of the β-globin locus in G1E cells expressing ZF85

SA proteins. Strikingly, expression of P-SA alone but not L-SA produced a strong HS2β-globin chromatin loop, recapitulating the chromatin conformation induced by GATA1
(Figures 3.5 B, C). Thus, recruitment of the SA domain to the β-globin promoter is
sufficient for juxtaposition with the LCR, likely via interaction with endogenous LCRbound Ldb1 (Figures 3.1A, Model in Figure 3.2A). Co-expression of P-SA and L-SA
triggered juxtaposition of HS2 with the β-globin gene with a similar efficiency as the PSA alone (Figure 3.5D). Given the lower levels of occupancy of P-SA at HS2 in
comparison to L-SA, it was surprising to find that P-SA was as active as the combination
of L-SA plus P-SA or GATA1. It is possible that the ChIP signal for P-SA at the LCR
under-represents the amounts of P-SA since proteins indirectly associated with DNA are
not cross-linked as efficiently. Moreover, P-SA association with multiple regions in the
LCR via endogenous Ldb1 likely adds to its ability to promote loop formation.
Nevertheless, forced LCR-β-globin chromatin looping correlated well with activation of
β-globin transcription.
In concert, these results show that tethering the SA domain of Ldb1 to the β-globin
promoter is sufficient to produce an LCR-β-globin chromatin loop that is similar if not
identical to that generated by GATA1. This strongly suggests that Ldb1 is an essential
rate-limiting effector of GATA1 during chromatin looping. More generally, juxtaposition
of an LCR with a promoter causes strong gene activation.
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3.3.5: ZF-SA expression produces LCR-dependent functions
Two of the key functions of the β-globin LCR functions are the recruitment of Pol II
to the β-globin promoter and stimulation of Pol II phosphorylation at serine 5 of its Cterminal domain, a modification associated with early transcription elongation (Sawado
et al., 2003). Hence, if ZF-SA proteins activate β-globin transcription by promoting LCRβ-globin contacts, they are expected to stimulate Pol II recruitment and serine 5
phosphorylation (Ser5ph). To examine the extent to which ZF-SA fusion protein restored
LCR-dependent function, we performed ChIP with antibodies against Ser5ph Pol II, or
antibodies that react with Pol II regardless of its phosphorylation state. Notably,
expression of P-SA triggered Pol II recruitment to the β-globin promoter with an
efficiency similar to that achieved by GATA1 expression (Figure 3.6 A, B). In contrast,
Pol II levels in the body of the gene amounted to approximately 25% to 30% of those
found in GATA1 expressing cells corresponding well with the levels of β-globin mRNA
production (Figure 3.3B). This is consistent with reduced recruitment of the elongation
complex P-TEFb to the β-globin promoter and the body of the gene when compared to
GATA1 expressing cells (as measured by anti-CDK9 ChIP, Figure 3.6 C). The amounts
of Ser5ph Pol II found at the β-globin gene in P-SA expressing cells were
indistinguishable from those observed in GATA1-expressing cells (Figure 3.7 A). As an
additional measure of transcription initiation, we determined the level of histone H3
lysine 4 trimethylation (H3K4me3), and found that P-SA restored this mark to levels
equal to that produced by GATA1 (Figure 3.7 B). Similar results were obtained in cells
co-expressing P-SA and L-SA (data not shown). These results demonstrate that two
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functions of the LCR, i.e. Pol II recruitment to the β-globin promoter and Pol II serine 5
phosphorylation were completely restored by expression of P-SA, lending additional
support to the idea that juxtaposition of the LCR with the β-globin promoter underlies the
activity of P-SA. The failure to fully restore transcription elongation can be explained by
the lack of GATA1 and its co-factors which exert additional, looping-independent
functions, possibly including the recruitment and activation of P-TEFb complex (Bottardi
et al., 2011; Elagib et al., 2008, see Discussion).
3.3.6: Precocious induction of β-globin transcription by ZF-SA fusion proteins in
primary erythroblasts
We examined whether ZF fusion proteins function in primary erythroid progenitor
cells to activate β-globin expression. The maturation stage of primary erythroid precursor
cells from E13.5 wild type fetal livers was monitored by flow cytometry measuring the
expression of the cell surface markers Ter119 and CD71 (Zhang et al., 2003). Cells
progress through the R1, R2, R3, and R4 stages of maturation (Figure 3.8 A), and
gradually increase expression of erythroid specific transcription factors (e.g. GATA1,
KLF1) and repress transcription factors of immature stage (e.g. GATA2, Kit) (Figure 3.8
B), and ultimately produce abundant amounts of α-globin and β-globin (Figure 3.8 C) .
For the expression of ZF-SA proteins we purified Ter119-, CD71-/low cells (R1 population
in Figure 3.8 A) representing early precursor cells. At this stage, the β-globin genes are
not yet highly active but cells express low levels of essential regulatory factors, including
GATA1 and KLF1 (Figure 3.8 C). Following infection with retrovirus expressing ZF-SA
fusion proteins, cells were cultured in defined medium containing cytokines IL-3, IL6
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and SCF to preserve the cells in the precursor state. Remarkably, expression of P-SA only
or P-SA/L-SA, but not L-SA alone precociously activated β-globin transcription (Figure
3.9 A). Note that the fold-activation over control was not as pronounced as that observed
in the G1E system, since in contrast to the latter, primary erythroblasts are replete with
transcription factors and produce higher levels of β-globin even prior to full maturation.
Nonetheless, these results in essence mirrored those from G1E cells in that the same
combinations of ZF fusion proteins were capable of activating β-globin expression. The
effects were specific to the β-globin locus as no other erythroid genes examined were
altered in their activities (Figure 3.9 A). Moreover, ZF-SA expression did not nonspecifically promote erythroid maturation as determined by flow cytometry using CD71
and Ter119 surface markers (Figure 3.9 B). Together, these results show that ZF-SA
fusion constructs can activate β-globin transcription in primary erythroid cells.
3.3.7: ZF-SA fusion protein induction of β-globin transcription is LCR-dependent
Targeting of the SA domain to the β-globin locus restores juxtaposition of HS2 with
the β-globin gene, Pol II recruitment, and Pol II serine 5 phosphorylation, strongly
suggesting that transcriptional activation is due to LCR- β-globin looping. The prediction
from these observations is that alleles lacking the LCR would not respond to ZF-SA
fusion proteins (Figure 3.10 A). Alternatively, if β-globin transcription simply resulted
from SA-induced transcription factor assembly at the β-globin promoter, ZF-SA should
activate transcription independently of the LCR. This distinction is especially important
in light of the positive effects on β-globin transcription exerted by the expression of P-SA
alone. To definitively distinguish between these possibilities, we examined ZF-SA’s
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functions in E13.5 fetal liver erythroblasts derived from mice that are heterozygous for a
deletion of the LCR (∆LCR/+) (Bender et al., 2000). The β-major gene on the ∆LCR
allele is of the D haplotype whereas that on the wild type allele is of the S haplotype. We
developed an allele-specific qPCR assay that distinguishes single nucleotide
polymorphisms between the transcripts of these alleles (Figure 3.11), providing an ideal
internally controlled experimental setup.
Next we transduced ∆LCR/+ R1 cells with viral vectors expressing ZF-SA proteins
and exposed them to erythropoietin (Epo) for 6 hours to promote erythroid maturation.
Allele-specific RT-qPCR demonstrated that the wild type allele (βmaj-S) was activated in
cells expressing L-SA together with P-SA, or P-SA alone (Figure 3.10 B, left panel). LSA had little or no activity similar to ZFs lacking SA that served as negative controls. In
striking contrast, the β-major gene on ∆LCR allele (βmaj-D) was expressed at low levels
and showed very little response to the P-SA/L-SA or P-SA proteins (Figure 3.10 B,
middle panel). The effects were specific to the β-globin locus as no other erythroid genes
examined were altered in their activities (Figure 3.10 C). The effects of ZF fusion protein
expression were the essentially the same in the presence or absence of erythropoietin and
specific to the β-globin locus as none of the other examined erythroid genes were altered
in their activities (Figures 3.12). The residual signal produced by the D-allele-specific
primers was not due to transcription from the D-allele but the result of crosshybridization with S-allele cDNA. This was demonstrated by template mixing
experiments showing that approximately 10% of the signal produced by the D-allelespecific primers derived from cross-reactivity with the S-allele cDNA (Figure 3.11).
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Indeed, when homozygous (∆LCR/∆LCR) R1 cells were transduced with P-SA, β-globin
activation was close to background, establishing that the low signal obtained with Dspecific primers in ∆LCR/wt cells was in fact due to cross-hybridization (Figure 3.10 B,
right panel). In concert, the results clearly demonstrate that the activity of ZF-SA proteins
is entirely dependent on the presence of LCR and hence on long-range chromatin
looping.
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3.4: Discussion
Here we employed a ZF targeting strategy to address critical questions concerning the
higher order organization of the chromatin fiber. Targeting the SA domain of Ldb1 to the
endogenous β-globin locus compensated to a significant extent for the loss of GATA1,
strongly suggesting that Ldb1 serves as an effector of GATA1 during chromatin loop
formation. Forced chromatin looping by ZF-SA proteins at a native gene locus caused
strong transcriptional activation, indicating that the juxtaposition of an enhancer with a
promoter causally underlies gene induction.
Expression of P-SA by itself produced effects very similar to those of P-SA and L-SA
co-expression. Several independent lines of investigation demonstrate that in P-SA
expressing cells, forced loop formation accounts for β-globin activation. First, 3C
experiments clearly showed that tethering the SA domain to the β-globin promoter
fostered genomic contacts that strongly resembled those induced by GATA1 with regard
to both their spatial configuration and efficiency. Second, SA domain recruitment
completely restored several LCR-dependent functions at the β-globin promoter, including
Pol II recruitment, serine 5 phosphorylation of Pol II, and H3K4 methylation. Third,
targeted deletion of the LCR dramatically reduced β-globin transcription without
diminishing the amounts of promoter-bound Ldb1 (Song et al., 2010). Therefore,
tethering Ldb1 or its SA domain to the promoter is not expected to produce such
pronounced effects without an involvement of the LCR. Fourth, P-SA and P-SA/L-SA
induction of β-globin expression was entirely dependent on the LCR, confirming an
underlying looping mechanism. The ability of P-SA to potently induce loop formation is
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most likely explained by its ability to interact with endogenous Ldb1-containing
complexes that reside at the LCR even in the absence of GATA1 (Figure 3.1)(Tripic et
al., 2009). In contradistinction, Ldb1 association with the β-globin promoter is entirely
GATA1-dependent, and hence might represent a critical and rate limiting step during
chromatin looping and high-level transcription.
The observation that the SA domain is sufficient to induce long-range chromatin
interaction implies that self-association of Ldb1 is a major molecular force tying together
anchored chromatin regions. Importantly, the SA domain can form multimers (Cross et
al., 2010) allowing for the formation of higher order complexes that might serve to
stabilize interactions between distant chromatin fragments. However, the SA-deleted
form of Ldb1 was also active, suggesting that the LID domain is also capable, albeit with
lower efficiency, of recruiting the endogenous Ldb1 complex to promote long-range
interactions.
While it is conceivable that in the simplest terms the mere dimerization of DNA
bound factors should be capable of inducing chromatin loops, we speculate that multiple
contacts are required to provide the requisite specificities and affinities. Moreover, the
folding of the chromatin fiber can occur in complex patterns involving simultaneous
interactions between multiple segments to form what are called chromatin hubs. Simple
protein dimers might be insufficient to accommodate such complex interaction patterns.
In agreement, fusion of ZFs with diverse dimerizering domains (lexA, p65NFkB, the
Argent™ dimerization system) or protein modules that can form multimers, such as the
POZ domain of GAGA factor failed to efficiently activate β-globin expression
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(unpublished observations). Thus, Ldb1 might have evolved to promote such interactions
by forming homo-multimers and by engaging numerous gene-specific transcription
factors, including the LMO2/TAL1/E2A complex and GATA1. Indeed, a widely used
and evolutionarily conserved looping function for Ldb1 is suggested by studies in diverse
organisms and cell lineages (Matthews and Visvader, 2003; Morcillo et al., 1997; Thaler
et al., 2002).
The cause-effect relationship between chromatin looping and gene regulation has
been unclear. By manipulating the chromatin conformation at a native gene locus, we
found that juxtaposition of an enhancer with its target gene leads to transcription
activation, indicating that looping is a prerequisite for transcription activation. In
particular, forced association between the LCR and the β-globin gene sufficed to exert
two functions ascribed to the LCR, the formation of a pre-initiation complex at the
promoter and the generation of early elongating Pol II as reflected in serine 5
phosphorylation (Sawado et al., 2003; Song et al., 2010). On the other hand, our
observation that ZF-Ldb1 proteins completely rescued chromatin looping but only
partially restored transcription elongation agrees with the notion that full transcription is
not required for loop formation (Jing et al., 2008; Mitchell and Fraser, 2008; Palstra et al.,
2008b). We speculate that juxtaposition of the LCR with β-globin promoter increases the
concentration of nuclear regulators at the promoter above a threshold critical for preinitiation complex formation and early transcription elongation (see model in Figure
3.13).
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Ldb1 recruitment in GATA1 null cells completely rescued chromatin looping and
transcription initiation, but only partially restored transcription elongation, indicating that
GATA1 contributes additional functions independently of Ldb1 and chromatin looping.
Indeed, both the recruitment of P-TEFb complex and its distribution along the gene were
impaired in the absence of GATA1, suggesting GATA1 impacts on P-TEFb regulation at
multiple levels, perhaps via direct interaction (Bottardi et al., 2011; Elagib et al., 2008) or
indirectly via proteins of the BET family (Lamonica et al., 2011). In addition, GATA1
interacts with many other transcription factors and histone modifiers, the lack of which
might account for inefficient transcription elongation.
In concert, these results suggest that Ldb1 functions downstream of GATA1 rather
than in a parallel pathway and highlight the usefulness of this system to interrogate
protein functions during distinct steps in the transcription cycle. In more general terms,
this work illustrates a novel strategy to establish hierarchical orders of transcription factor
function. On the background of a transcription factor deficiency, forced tethering of a
potential co-factor to a chosen gene can be employed to measure its contribution to
defined steps in the transcription cycle, such as loop formation, Pol II recruitment, Pol II
phosphorylation, and productive transcription elongation. We believe that this approach
is widely applicable for any nuclear factors that can be knocked down or knocked out.
One key general finding of our study is that a single ZF-Ldb1 protein targeted to the
β-globin promoter can induce a chromatin loop by interacting with endogenous LCRbound factors. ZFs have previously been linked to activation domains to successfully
activate gene expression (Klug, 2010). However, the use of ZFs to promote interactions
95

with a potent enhancer or LCR is expected to produce more pronounced transcriptional
effects. Indeed, we are not aware of any single ZF proteins capable of activating gene
transcription by a factor of more than a 1000-fold. Another advantage of a forced looping
approach by a single ZF construct, especially in the context of therapeutic applications, is
that efficient expression of a single molecule is easier than co-expression of two factors at
matching levels.
Finally, specific chromatin loops can occur at repressed genes (Jing et al., 2008), and
placing an enhancer and promoter on separate loops can isolate the enhancer to render it
inactive (Ameres et al., 2005; Hou et al., 2008). Thus, in addition to activating
transcription, we envision that forced chromatin looping could be used to silence gene
expression for scientific or therapeutic purposes.

3.5: Figures
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Figure 3.1. ZFs targeting of the β-globin locus. (A) Anti-GATA1 (top) and anti-TAL1
(middle and bottom) ChIP-seq tracks encompassing the β-globin locus from parental
G1E cells (middle) and G1E cells expressing induced GATA1-ER (top, bottom). TAL1 is
a reliable indicator for the presence of Ldb1 since their occupancy patterns are virtually
identical (Tripic et al., 2009). Note that in the absence of GATA1, TAL1 is completely
lost from the β-major globin promoter but not the LCR. (B) L-ZF and P-ZF target HS2 of
the LCR (red oval) and the β-major promoter (red triangle), respectively. The DNA
sequences used for ELISA experiments are shown, including 18 nucleotides of ZF
binding site (uppercase) and the flanking nucleotides (lowercase). Anti-HA ChIP profiles
of HA tagged P-ZF (C) and L-ZF (D) in G1E cells were shown. N=3; error bars denote
standard deviation.
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Figure 3.2. ZF-mediated targeting of Ldb1 to the β-globin locus. (A) Experimental
model. Top: wild-type scenario in which GATA1 and the TAL1 complex recruit Ldb1 to
promote chromatin looping. Middle: lack of GATA1 leads to loss of Ldb1 at the
promoter, impaired looping, and reduced transcriptional activation. Bottom: ZF-mediated
Ldb1 tethering to the β-globin promoter is examined for its ability to restore looping and
transcription activation. (B) Top: P-ZF and L-ZF target the β-major promoter (red
triangle) and HS2 of the LCR (red oval), respectively. (B-D) Anti-HA ChIP in cells
expressing P-Ldb1 (B), L-Ldb1 (C), and L-Ldb1+P-Ldb1 (D). L-Ldb1 binds selectively
to HS2 of the LCR. Of note, P-Ldb1 binds to the promoter but additionally associates
with HS 1, 2, 3 of the LCR but not to other regions, including the εy, βH1, and βmin
genes, an intervening region (IVR16) or an inactive gene (CD4). N≥3; error bars denote
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Figure 3.3. Activation of β-globin transcription in GATA1 null cells by tethered
Ldb1. (A) β-major mRNA levels as measured by RT-qPCR with primer pairs for exon 2
in G1E cells and derivatives expressing indicated ZF and ZF-Ldb1 constructs. (B) Data in
(A) were re-plotted next to those obtained from induced G1E-ER4 cells (G1E+GATA1).
Note that β−major expression achieved by P-Ldb1 or L-Ldb1+P-Ldb1 amounts to
approximately 20% of that induced by GATA1. (C) β-major mRNA levels in ZF-Ldb1
expressing cells as measured by RT-qPCR with primer pairs for exon 2/3 junction, 5UTR
and 3UTR. (D) Relative expression of indicated erythroid genes as determined by RTqPCR. Transcript levels were normalized to β-actin. N≥3; error bars denote standard
deviation.
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Figure 3.5
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Figure 3.5. Chromatin looping by the tethered Ldb1 self-association domain. (AD) 3C assay measuring locus wide cross-linking frequencies in G1E cells (blue) or
induced G1E-ER4 cells expressing GATA1 (A, red), or G1E cells containing P-SA (B,
red), L-SA (C, red) or L-SA+P-SA (D, red). The murine β-globin locus is depicted on top
of each graph. The X-axis indicates distances (kb) from the εy gene, which represents
zero. Black bar denotes the HS2-containing BglII fragment serving as anchor. Grey bars
denote analyzed BglII fragments. N=3 (A,B,D), and N=2 (C). Error bars indicate
standard-error-of-mean.
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Figure 3.6
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Figure 3.6. Recruitment of Pol II and CDK9 by ZF-SA expression. (A) Location
of amplicons (black bars). Prom, promoter; numbers indicate exons. (B, C) ChIP profiles
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Figure 3.7
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Figure 3.8
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Figure 3.8. Staging of E13.5 fetal liver erythroid cells. (A) Isolation and FACS profile
of E13.5 fetal liver erythroid cells staining with Ter119 and CD71 antibodies. (B, C)
mRNA level of indicated genes in R1 to R4 populations of fetal liver cells as measured
by qPCR. N=3; error bars denote standard deviation.
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Figure 3.9
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Figure 3.9. ZF-SA specifically enhances β-globin expression in primary early
progenitor cells. (A) mRNAs from FACS purified R1 cells transduced with ZF
constructs were examined by RT-qPCR with primers for the indicated genes. Negative
controls (Neg Ctrl), cells expressing empty vector. Results were normalized to GAPDH.
N=3; error bars denote standard deviation. (B) Differentiation profiles of R1 cells
expressing indicated constructs as measured by flow cytometry using Ter119 and CD71
surface markers.
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Figure 3.10
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Figure 3.10. LCR-dependence of β-globin induction by ZF-SA proteins. (A)
Experimental concept. The LCR deleted allele is on the background of the β-major D
haplotype while the wild type allele is of the β-major S haplotype. (B) β-major transcript
levels as measured by allele-specific RT-qPCR in R1 cells from WT/ΔLCR or
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expressing indicated ZF-SA proteins. Transcript levels were normalized to GAPDH.
N=3; error bars denote standard deviation.
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Figure 3.11
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Figure 3.11. Allele-specific qPCR. (A) β-major mRNA levels of D and S haplotypes as
measured by qPCR using allele-specific primers βmaj-D and βmaj-S, respectively. cDNA
from D haplotype or S haplotype was prepared from 129 or BL6 mouse strains,
respectively. Note that the βmaj-S primer specifically amplified BL6 cDNA but not 129
cDNA. In contrast, the βmaj-D primer cross-amplified BL6 cDNA with an efficiency ~
10% of the βmaj-S primer. Allele specificity was further examined by mixing D-cDNA
and S-cDNA templates. The observed qPCR signal (C) largely matched the expectation
(B) for allele-specific qPCR. The βmaj-S signal remained unchanged with increasing
amount of D cDNA verifying its amplification specificity. However, increasing the
proportion of S cDNA led to an augmented signal with the D-specific primers indicative
of cross-reactivity up to ~ 10%.
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Figure 3.12
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Figure 3.12. LCR-dependence of β-globin induction by ZF-SA without Epo
treatment. mRNA levels of β-major from D or S alleles (A) or indicated genes (B) in R1
cells from WT/ΔLCR fetal livers expressing indicated ZF-SA proteins. R1 cells were
transduced with ZF-SA expression constructs without Epo treatment. N=3; error bars
denote standard deviation. mRNA levels were normalized to GAPDH. N=3; error bars
denote standard deviation.
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Figure 3.13
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Figure 3.13. Hypothetical model functionally integrating chromatin looping and
transcription activation. Recruitment of Ldb1 to the β-globin promoter either by ZF
proteins or GATA1 promotes LCR-promoter looping. Forced chromatin looping by ZFLdb1 efficiently restores PIC assembly, Pol II recruitment, Pol II serine 5
phosphorylation, and transcription initiation. In the absence of GATA1, diminished
recruitment of P-TEFb and likely additional GATA1 co-factors accounts for inefficient
transcription elongation. Therefore, chromatin looping can trigger transcription initiation
and can occur independently of full transcription elongation.
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3.6: Additional Result: Optimization of 3C assay
Chromosome conformation capture assay is to analyze the organization of
chromosomes in the natural state of a cell by measuring relative proximity of paired
chromatin regions (Figure 3.14). Cells are first cross-linked by formaldehyde to conserve
the natural conformation of chromosomes. Chromosome DNA is subsequently digested
by restriction enzymes. Interacting chromatin fragments are in the same chromatin
particles hence the digested ends of DNA fragments are ligated with a higher efficiency
than those that are not interacting. qPCR using a primer pair against two digested ends of
interest is used to measure the amounts of specific ligation products of the two DNA
molecules. Interacting chromatin fragments have a higher crosslinking frequency, thus
producing more ligated DNA templates and generating higher qPCR signals.
3C assay has been wildly used to detect chromatin interactions spanning kilobases to
megabases, at a much higher resolution than DNA FISH. However, a successful 3C assay
requires numerous proper controls and protocol optimizations for a particular cell type. It
is challenging to detect long-range chromatin interactions, because the majority of
ligation products of a chromatin fragment is from self-ligation to its ends and ligation to
its neighboring fragments. Ligation of two bona fide interacting chromatin segments,
such as β-globin locus, occurs at a frequency of less than 1% (Simonis et al., 2007). This
means there are only a few ligated DNA molecules of interest in a “sea” of DNA
molecules from a thousand genomes. Hence a sensitive and accurate quantification
approach is essential. We used taqman qPCR to detect the ligated DNA templates using
random ligation product of BAC DNA as standard. The quality of primers are assayed as
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in Figure 3.15 A-C. There are five major steps of 3C, crosslinking, digestion, ligation,
DNA purification, and quantification (Hagege et al., 2007). Efficiency of each step
influences the occurrence of ligation of interacting chromatin fragments. Therefore,
extensive trials have been done to optimize each of the five major steps. The detailed
protocol is as below and rationales or caution are also commented.

Figure 3.14. Schematic presentation of 3C assay (adapted from (Kadauke and Blobel,
2009)).
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Figure 3.15. 3C quality controls. (A) A representative gel electrophoresis of BAC
DNA. BAC DNA was purified (lane 2), digested with BglII (lane 3), and ligated with T4
ligase (lane 4) to generate random ligation products of BglII fragments that served as
standard DNA for the 3C assay. (B) Linearity of representative 3C primers was tested
using serially diluted BAC DNA as template. (C) Amplification products of
representative 3C primers were analyzed by agarose gel electrophoresis to verify primer
specificity. (D) Digestion efficiencies at HS2 site of a representative 3C experiment.
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Optimized 3C protocol for G1E cells and comments
Day0: Preparation
(1) Make fresh 20% TritonX-100 solution (1ml stock to 4ml water, cover with tin foil and
rotate to dissolve).
(2) Prepare cell samples, for example, induce G1E-ER4 cells with 100nM E2.
Day1: Cross-link and digestion
1. Count 10X106 log-phase cells, spin down and resuspend in 20ml room temperature
(RT) PBS and then transfer to a new 50ml tube. Pipette up and down, in order to make
single cell suspension.
2. Add 37% formaldehyde 850 ul (1.5% final). Gently mix and then put in a box and
shake in horizontally circular motion on the shaker at speed 3, at RT for 10 min.
[ Test the cross-linking condition for any new cell type. Try 1-2 % formaldehyde for 510 min at RT; Higher formaldehyde is used to detect longer-range interactions, e.g.
Inter-chromosomal interaction. ]
3. Quench with 0.4 g Glycine powder ( the final concentration is ~0.25M) . Shake in
horizontally circular motion on the shaker at speed 3, at RT for 5 min. Store on ice for
10 min.
4. Spin down by swing bucket centrifuge, 2000 rpm (>~400g), 5 min, 4°C.
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5. Remove carefully the supernatant and wash 10 mL ice-cold PBS, spin down @ 2000
rpm, 5 min, 4°C. Remove sup.
[ PBS wash is to remove any residual formaldehyde.]
6. Resuspend cell pellet in 1.5 ml cold cell lysis buffer with protease inhibitor. Pipette up
and down to resuspend the pellet. Store on ice for 20 min.
[ Cell lysis buffer contains 0.2% NP40 that breaks the cytoplasmic membrane but not
nuclear membrane. ]
7. Lyse with cold Dounce Pestle A. (10 strokes/sample). Transfer to 1.7mL tube.
[ Generating homogenous nuclei is essential for the next digestion step. For initial
rounds of experiments, take 2 ul sample +2ul H2O +16ul typan blue, and check
under microscope to ensure cell plasma membrane is lysed well. Nuclei should be
intact and all stained with typan blue. Otherwise, repeat step 6 and 7. ]
8. Collect nuclei by swing bucket centrifuge, 2000 rpm (>~800g), 5 min, 4°C.
9. Resuspend the collected nuclei in 800 ul of cold appropriate 1.2XNEB buffer (buffer 3
for Bgl II).
10.

Collect nuclei by swing bucket centrifuge, 2000 rpm (>~800g), 5 min, 4°C.

11.

Pipette up and down to resuspend well in 500 ul of 1.2X RE buffer, avoid air

bubble. (500 * 1.2= 600 ul in total)
[ Single nuclei suspension is extremely important! Aggregation of nuclei profoundly
interferes with the digestion efficiency. ]
122

12.

Add 7.5ul of 20% SDS (to a final concentration of 0.3%). Incubate with shaking

at 950 rpm in a Thermomixer for 1 h at 37°C.
[ Our and Dekker’s protocol us 0.1% SDS, 65°C for 10 min. However, De Latt’s and
Fraser’s protocol use 0.3% SDS, 37°C for 1 hour; Chris Vakoc’s protocol (Vakoc et
al., 2005) was 0.1% SDS, 37°C for 15 min. My understanding is that the purpose of
this step is to disrupt nuclear membrane, which can be achieved at 37°C, and may
additionally remove the non-chromatin-bound proteins in the nucleoplasm. ]
13.

Add 50ul of 20% Triton X-100 (to a final concentration of 1.8%). Incubate with

shaking at 950 rpm for 1 h at 37°C.
[ The presence of SDS inhibits enzymatic reaction. In contrast, TritonX-100 is nondenaturing detergent and its presence doesn’t interfere enzyme activity much. TritonX100 can form micelles with SDS and therefore “hide” SDS from proteins. Eight or
more fold of TritonX-100 over SDS has shown to completely abolish the inhibition of
enzyme activity by SDS (Russell, 1979). TritonX-100 is light sensitive, so keep it in
dark and it is essential that working solution is relatively fresh. I always make it fresh
one day before the experiment. ]
14.

Take out 10 ul as undigested sample. Label as “UND”, store at -20°C.

15.

Add 800 U (16ul 50U/ul) of Bgl II to digest with shaking at 950 rpm overnight at

37°C. (Bgl II is not active more than 8hrs, add extra enzyme at next morning or after
8hrs later)
[ Single nuclei suspension is extremely important! Aggregation of nuclei profoundly
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interfere digestion efficiency. So make sure to resuspend cells well, and if see
aggregates during digestion, pipette up and down to resuspend again. ]
Day 2: Ligation and reverse cross-link
16.

At AM, Add another 400 U (8ul) Bgl II and shake at 950 rpm 37°C, 2 hours.

[If see aggregates, pipette up and dow to resuspend again. ]
17.

Take 10ul (out of 600ul) as digested sample and label as “DIG”. Take out the

UND samples. Add 190ul PK buffer (TE+0.5%SDS), 3ul 20ug/ul proteinase K and
2ul RNase. 65°C overnight.
18.

Add 40ul of 20% SDS (final 1.6%) incubate in thermalmixer at 65°C, 950rpm,

25 min.
[SDS is to deactivate Bgl II, which can not be deactivated by heating. Aggregated
nuclei particles are dispersed at this point due to SDS.]
19.

Transfer the sample to a 15-mL centrifuge tube, add 750ul 10X Ligase buffer

(home-made), and 375 ul 20% Triton X-100 (final 1%), and 75ul 10mg/ml BSA, and
5.7 mL H2O. Incubate at 37°C water bath for 1hr. The total volume is 7.5 ml.
[Triton is to “hide” SDS from last step. Acetylated BSA is reported to confer stability
to T4 DNA ligase.]
20.

Chill samples on ice. Add 75 ul of 100mM ATP (final is 1mM).

[ The pH of ATP stock should be adjusted to pH7.5, and stock solution should be kept
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in -20°C, after thawed, ATP should be stored on ice. Degradation of ATP can lead to
inefficient ligation and profound interference of 3C results. ]
21.

Add 4000 U (10ul X 400U/ul) T4 DNA ligase (NEB) and incubate at 16C water

bath for 4 hrs.
22.

Room temperature for 30 minutes.

23.

Add 160ul of 0.5M EDTA to stop reaction.

[ T4 ligase can be heat inactivated by 65°C incubation for 10 min, so this step may not
be necessary. ]
24.

Add 50ul of 20 mg/ml Proteinase K, incubate in 65°C waterbath overnight.

[ This is to reverse cross-linking.]
25.

Purify “UND” and “DIG” samples with attached protocol (see below).

Day 3: DNA purification
26.

Add another 25ul proteinase K, 55°C 2hour.

[ Extra protein digestion time. Proteinase K retains high activity in from pH 6.5-9.5,
temperature 20-60°C and in the presence of up to 0.5% SDS.]
27.

Cool to RT. Transfer to 50 ml conical tube. Extraction with 10ml pH 8.0

phenol/chloroform/isoamyl alcohol (PCI), vortex 30 sec, hand shake 1-2min. Spin at
2,460Xg (3,500rpm) for 10 min at RT. Take supernatant. Extract twice.
[ Adjust pH of PCI to pH8 because it is optimal for DNA extraction. Pipette as much
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material as possible close to the interface because the DNA accumulates there during
the first extraction, but do not carry any interface material into the fresh tube.]
28.

Extraction with 8ml chloroform extraction once. Vortex 30 sec, hand shake 1-

2min. Spin at 2,460Xg (3,500rpm) for 10 min at RT.
29.

To the supernatant, add ~3ml H2O to bring final volume to 10ml. Add 1 mL 3M

NaAc (1/10 Volume, pH5.2), invert to mix, add 25 mL (2.5 volume) RT 100%
ethanol, invert to mix. Place at -80°C for 20min.
30.

Pellet DNA by spinning in swing bucket at 3500 rpm (2,460Xg ) for 30 min, at

4°C.
[ Pellet after this step could be white and big, presumably due to DTT precipitation.
SDS precipitation is possible too]
31.

Wash with 20 ml 70% ETOH, spinning at 3500 rpm for 20 min, at 4°C.

32.

Air dry for 5 min. Resuspend pellet in 400ul 10mM Tris pH8 buffer. Add RNase

2ul , incubate 37°C waterbath for 30 min.
[ RNA digestion after 1st DNA precipitation is to make RNA digestion more efficient
and also to reduce the reaction volume.]
33.

Extract with 400ul PCI. Votex 30 sec. Max spin 5 min. Take aqueous, extract

again. Extract with 400ul Chloroform. Votex 30 sec. Max spin 5 min.
34.

Take aqueous, add 40ul Na Acetate and 1.1ml RT 100%ETOH, invert to mix. Put

on ice for 30 min.
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35.

Spin at max speed for 30 min at 4°C.

36.

Wash with 1ml cold 70% ETOH, for 5 times if needed.

[ These wash steps are necessary to remove extra salt from DNA pellet. Pellet size
should reduce obvious after two washes. I usually do 3 times of wash]
37.

Resuspend in 200ul 10mM Tris pH8 buffer. To help DNA to dissolve, incubate in

55°C waterbath for 10 min, and leave at 4°C fridge overnight.
38.

Run 6 ul (equivalent to 0.3 million cells) on 0.8% agrose gel.

Day 4: Quantification of 3C
39.

For detailed quality control and qPCR set-up, please refer (Hagege et al., 2007).

Below are a few additional comments.
- Digestion efficiency should be at least 60%, preferably ≥ 80%.
- Dilution of 1:4 or 1:8 usually works well for 3C library from 10 million G1E cells.
- Setup of PCR reaction: (10ul for 384-well plate)
2xTaqman master mix

5ul

Primer (9uM)

1ul

Probe (2.5uM)

1ul

3C sample

2ul

H2O

1ul
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CHAPTER 4: Conclusions and Future Directions
In this thesis, I have addressed how the activity of GATA1 at its target genes is
determined, how GATA1 induces long-range chromatin interaction, and more
importantly what the relationship is of chromatin looping and transcription regulation. I
have defined a multi-protein complex, SCL/Ldb1/LMO2/E2A, as a critical and consistent
determinant of positive GATA1 activity in multiple hematopoietic lineages. I have
uncovered Ldb1 as a potent looping factor that mediates GATA1-induced chromatin
looping. I have for the first time forced a long-range chromatin interaction at an
endogenous locus in its native environment, and demonstrated chromatin looping
causally underlies transcription activation. In the following sections, these conclusions
will be discussed in greater depth, and follow-up experiments will be suggested to expand
this work in several new directions.
4.1. Ldb1 as a looping factor
The observation that simply anchoring Ldb1 protein to the β-globin promoter is
sufficient to establish a LCR-β-globin loop demonstrates that Ldb1 functions as a looping
factor that can build specific physical interactions between distant regulatory elements.
The SA domain of Ldb1 is functionally equivalent to the full-length Ldb1 in inducing
chromatin looping, implying that self-association of Ldb1 is a major molecular force
tying together anchored chromatin segments. Hence it might be possible to induce
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chromatin loops by targeting interacting domains from heterologous proteins that are not
normally expressed in erythroid to specific chromatin regions. If successful, this will
provide important insights into mechanisms of loop formation and functions of chromatin
looping on transcription regulation since heterologous domains do not interact with
endogenous proteins and any of their effects on looping and transcription will be direct.
Our preliminary trials using dimerizing or multimerizing domains from bacteria or yeast
were not successful in inducing chromatin loops, suggesting Ldb1 might have some
unique properties to function as a looping factor. Such unique properties may reside in its
self-association or unknown functions, and this is a direction worth investigating in the
future. Moreover, we and others found that Ldb1 binds to numerous intergenic regions as
well as gene promoters in erythroid cells, so it is plausible that Ldb1 might function as a
general looping factor linking distant chromatin segments. Therefore, we will
characterize chromatin interactions among Ldb1-bound sites on a genome-wide scale,
which will in turn help to understand the roles of Ldb1 in chromatin looping.
4.1.1: Heterologous systems for forcing chromatin loops
Our studies show that self-association of Ldb1 is likely a major molecular force
anchoring the LCR-β-globin chromatin loop. To extend our studies, we aim to force
specific chromatin loops using interacting domains from heterologous proteins. In our
preliminary studies, targeting diverse dimerizering domains (lexA, p65NFkB, the
Argent™ dimerization system) or the multimeric POZ domain of GAGA factor to both
the β-globin promoter and HS2 failed to efficiently activate β-globin expression,
suggesting that Ldb1 has some unique properties in inducing looping at least in the
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context of the β-globin locus. First, the unique properties might simply reside in strong
association affinity of the SA domain. In this regard, further studies to measure the
association affinity of various interacting domains are required. Second, the SA domain
of Ldb1 forms dimers, and even larger oligomeric complexes at high concentration
(Cross et al., 2010). Third, Ldb1 binds multiple HSs of the LCR including HS2. It is
conceivable that its binding at multiple HSs and oligomerization allow simultaneous
interactions among HSs of the LCR and the active β-globin promoter that might in turn
serve to stabilize complex interactions. Thus, in order to improve the design of
heterologous looping systems, we will target domains that self-associate with high
affinity to multiple HSs of the LCR and β-globin promoter. We also aim to generate
inducible chromatin loops using a drug-inducible association system, which, if
successful, will be critical to isolate roles of chromatin looping and dissect steps of
transcription activation by time-course studies. To this end, it is worth considering the
following approaches.
(i) From ours and others’ studies on artificial ZFs, it is clear that they have a number
of limitations, including expense, off-target binding, and the requirement for extensive
screening for the optimal ZFs. In contrast, recently developed DNA binding proteins
from the plant pathogen Xanthomonas, transactivator-like effector protein (TALE, (Boch
and Bonas, 2010)) , have been successfully used in gene targeting with high efficiency at
much lower cost (Cermak et al., 2011; Mahfouz et al., 2011; Miller et al., 2011). TALE
proteins can be produced conveniently and efficiently using commercially available
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cloning kits. Hence we will produce TALE proteins targeting multiple HSs of the LCR or
any sites of interest in future.
(ii) As mentioned in Chapter 3, besides homodimer domains, we have tested the
chemically induced proximity (CIP) ArgentTM system that uses FK506 and rapamycin
analogs to make inducible heterodimers, aiming to produce inducible chromatin loops.
We observed transient and weak LCR-β-globin interactions but conclusions were limited
due to toxicity of the dimerizing agent. Very recently, the same group that developed
rapamycin CIP system developed a potent and non-toxic CIP system that uses the plant
hormone abscisic acid (ABA) (Liang et al., 2011). We can adopt this system by fusing
the two heterodimeric domains of the ABA CIP system to ZF or TALE proteins that
target either the β-globin promoter or HSs of the LCR. The dynamics of loop formation
will be assessed upon ABA induction of dimerization. If successful, we can further apply
this system to study other processes that involve long-range chromatin interaction, such
as transcription repression, insulation, and gene positioning in nucleus.
4.1.2: Mechanisms of Ldb1 functioning as a looping factor
Our studies demonstrate Ldb1 or its SA domain is sufficient to induce a chromatin
loop in the absence of GATA1. The SA domain contains 200 amino acid residues and is
folded into multiple structural domains (Cross et al., 2010). Yeast two-hybrid analysis of
SA mutants with deletion of terminal residues show that the first N-terminal 14 residues
are dispensable for its self-association and any further deletion from its N-terminus or Cterminus disrupts its self-association (Cross et al., 2010). To further investigate the roles
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of Ldb1 self-association in chromatin looping, we will systematically make deletions
within the SA domain and identify a mutant that disrupts self-association with minimal
deletion. Based on our model that self-association of Ldb1 contributes to chromatin
looping, the mutant SA domain is expected to be incapable of inducing looping.
Although we have demonstrated that the SA domain is sufficient to induce chromatin
loops, the possibility that its interacting factors also contribute to loop formation has not
been excluded. Ldb1 does not bind to DNA directly but is recruited to chromatin as a
component of DNA-binding complexes, such as the SCL/LMO2/E2A/GATA complex in
erythroid cells (Soler et al., 2010). Depletion of Ldb1 or GATA1 reduces LCR-β-globin
loop formation (Song et al., 2007; Vakoc et al., 2005). However, GATA1 per se might
not be sufficient to induce chromatin loop as suggested by studies of mice containing a
hypomorphic allele of the chromatin remodeler Brg1. In fetal liver cells of these mutant
mice, β-globin looping and transcription are defective although GATA1 binds to β-globin
promoter and the LCR at the same level as wild type (Kim et al., 2007; Kim et al., 2009).
Depletion or mutation of Brg1 interferes with chromatin occupancy of SCL but not
GATA1, (Hu et al., 2011; Kim et al., 2007), suggesting reduced β-globin looping
observed in the Brg1 mutant mice attributes to deficient chromatin binding of the SCL
complex.
It is notable that in genome-wide occupancy studies in different cell types, the great
majority of long-range enhancer-promoter interactions appear to involve CTCF,
mediator, and cohesin (Dixon et al., 2012; Kagey et al., 2010). It is therefore possible that
Ldb1 directly or indirectly associates with these proteins. Prior conventional Ldb1
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affinity purification/mass spectrometry studies have failed to uncover any of these
proteins and mostly identified the previously known Ldb1 partners (the SCL complex)
(Meier et al., 2006). It is possible that specific interactions with any of the other
molecules involved in looping might have been obscured by background or non-specific
interactions, especially if their stoichiometry is lower than that of the direct binding
partners. It is also possible that these interactions might occur stably only in the context
of chromatin and are disrupted upon lysis and harsh nuclear extraction. Therefore, future
efforts to identify unknown partners of Ldb1 require a sensitive approach to identify
weak interacting partners.
4.1.3: Interactome of Ldb1-bound chromatin
Ldb1 binds to numerous intergenic sites as well as proximal promoters, suggesting
that it coordinates long-range genomic interactions at many gene loci (Soler et al., 2010).
In agreement, knockdown of Ldb1 impairs enhancer-promoter looping and reduces
expression of the Myb (Stadhouders et al., 2012) and the α-globin genes (Song et al.,
2010). Moreover, ChIP-seq and limited-scale 3C-on-chip studies showed that binding
sites of the Ldb1-containing complex partially overlap with chromatin regions that
physically interact with the active β-globin promoter, including genes with similar
expression patterns (e.g. Uros) as well as widely expressed genes (e.g.Tspan32,
Suv420h2 and Cox6b2) (44). Thus, in mature erythroid cells Ldb1 might spatially
connect regulatory sites that are bound by the SCL/GATA1 complex. Together with
studies of Drosophila Chip, these observations suggest that Ldb1 coordinates chromatin
organization on a broad scale as part of a conserved function. Note that the SCL complex
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largely favors activated over repressed genes (Cheng et al., 2009; Soler et al., 2010;
Tripic et al., 2009), suggesting that Ldb1 functions by juxtaposing positive regulatory
elements. Interestingly, ~22% of Ldb1 occupied sites are not bound by GATA1 or SCL
(Soler et al., 2010), suggesting additional mechanism of Ldb1 recruitment and possibly
involvement in GATA1-independent loop formation. These observations suggest that
Ldb1 might function in multiple distinct modes of organizing chromatin throughout the
genome. Therefore, to reveal Ldb1’s functions in chromatin organization, it is crucial to
delineate the chromatin interaction profile established by Ldb1.
To paint a complete picture of Ldb1 associated chromatin interactions (“chromatin
interactome”) we plan to perform Ldb1 ChIA-PET in erythroid cells. ChIA-PET
combines chromatin IP with antibodies against a factor of interest (e.g. Ldb1) with 3C
ligation and massive parallel sequencing (Fullwood et al., 2010; Fullwood et al., 2009). It
depicts the interaction profiles of chromatin segments bound by the factor of interest on a
genome-wide scale (Fullwood et al., 2010). ChIA-PET profiles of Ldb1 will be analyzed
in GATA1-null G1E cells and induced G1E-ER4 cells expressing active GATA1 to
identify Ldb1’s functions in GATA1-dependent loop formation. The following questions
will be addressed. (1) Is Ldb1 broadly involved in looping? ChIA-PET results can be
used to compare genome-wide chromatin interactions with Ldb1 genomic binding
patterns. Large overlap of these two would suggest a general role of Ldb1 in mediating
chromatin loops. (2) What are the characteristics of chromatin loops regulated by Ldb1?
We can characterize loop size, locations in the genome, cis or trans, and their
relationships with transcription activity. (3) Which elements/factors utilize Ldb1 to form
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chromatin loops? We anticipate that chromatin interactions may occur between two Ldb1
bound sites (e.g. the LCR and promoter at the β-globin locus) or between an Ldb1 bound
and an unbound site. For example, at the Myb locus, multiple Ldb1-occupied distal
enhancers contact the Myb promoter that lacks Ldb1 (Stadhouders et al., 2012). Genomic
sites to which Ldb1-occupied elements loop that do not bind Ldb1 might identify new
nuclear proteins that utilize Ldb1 for looping. Motif finder programs such as MEME and
DREME can be employed to examine contact regions for known or new cis-elements
enriched in Ldb1 associated regions. By combining these analyses with existing Ldb1
ChIP-seq data, knock-downs, and transcriptome studies, we expect to identify new
factors that function via Ldb1 recruitment. Some of these might be amenable to
regulation by targeted tethering of Ldb1, similar to the studies of the globin locus. (4) To
what extent does Ldb1 regulate the chromatin interactome in erythroid cells? In other
words, are co-regulated genes or genes that depend on Ldb1 co-localized in the nucleus,
similar to what has been proposed for Klf1 regulated genes (Schoenfelder et al., 2010b)?
Select chromatin interactions will be validated by conventional 3C and/or DNA-FISH.
Their dependence on Ldb1 will be investigated by Ldb1 knockdown experiments.
Ldb1 is essential for cell fate determination and cell differentiation in many tissues. It
is possible that Ldb1 is employed by DNA-binding transcription factors in various cell
types to mediate specific chromatin loops and hence regulate the transcription program.
This aspect can be further explored in HSC and many other hematopoietic lineages in the
future.
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These proposed studies would provide important insights on the mechanisms of
chromatin loop formation and how a non-DNA-binding co-factor can be employed by
tissue-specific transcription factors to facilitate chromatin looping.
4.2. Modulate gene activity by forced chromatin looping
In our studies, forced chromatin looping of β-globin with the LCR leads to Pol II
recruitment and transcription activation in the absence of GATA1. Therefore, forcing
chromatin looping can possibly be used to modulate gene activity in cells. We envision
that linking a gene with its native enhancers would lead to potent gene activation that is
likely superior to existing strategies that simply targets a heterologous activator to the
gene (Sera, 2009). This would be useful for controlling gene expression for research and
therapeutic purposes.
4.2.1: Developmental reprogramming of the murine β-globin locus
Activity of β-globin locus is under tight temporal and spatial control such that
erythroid cells at different developmental stages, including embryo, fetus and adult,
abundantly express stage-specific β-globins with other globin genes silenced (Chapter
1.3). The LCR switches its interactions with the β-globin genes and confers high-level
expression of the stage-appropriate globin genes (Palstra et al., 2003). For example, in
adult murine erythroid cells, β-major and β-minor globin genes are active and form
chromatin loops with the LCR, while the embryonic globin genes, εy and βh1, are in a
repressed state and looped out (Figure 1.6). A few recent studies provide new insights
into the molecular mechanisms that mediate this developmental switch by showing that
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transcription factors KLF1 and BCL11a are important regulators of this process (Borg et
al., 2010; Sankaran et al., 2008). Can forced loop formation be used to alter the
developmental expression pattern of the β-globin genes? In other words, can forced loop
formation override the repression mechanisms at the silent globin gene?
To answer these questions, we will examine whether targeting the SA domain to the
silent embryonic globin genes in adult erythroid cells can redirect the LCR from adult to
embryonic globin genes, and whether it can re-activate transcription of the embryonic
globin genes. Specific ZF or TALE proteins that target the embryonic βh1 gene will be
designed (Figure 4.1 A) and fused with the SA domain of Ldb1. The fusion protein will
be expressed in G1E or G1E-ER4 cells and their effects on chromatin looping and
transcription activation will be studied.
Below are some preliminary results of the experiments proposed above.
We first engineered ZF proteins to target the βh1 promoter (βh1 P) in collaboration
with Sangamo Biosciences and screened for the specific ZFs by ChIP. βh1 P-SA binds to
the βh1 promoter but not the βmaj promoter or any of the HSs of the LCR (Figure 4.1).
P-SA and L-SA (ZF-SA targeting HS2 of the LCR) were expressed alone or together in
G1E cells or G1E-ER4 cells. Our first experiments are promising. βh1 transcription was
activated about 200-fold over background when βh1 P-SA is expressed alone or in
combination with L-SA (Figure 4.2 A). L-SA does not affect βh1 expression as we have
observed before. Activation of βh1 by ZF-SA is also observed in G1E-ER4 cells induced
with estradiol (Figure 4.2 B). Note that βh1 transcript levels are much higher in induced
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G1E-ER4 cells than those in G1E cells (compare the y axis value of Figure 4.2 A and B),
indicating ZF-SA activates βh1 transcription together with GATA1. βh1 activation by
ZF-SA protein is substantial as the βh1: total globin ratio is elevated from less than 1% to
about 20% (compare left and right panels of Figure 4.2 C). This result is remarkable since
it shows that redirecting the LCR to the βh1 promoter at least partially overrides the
strong constraints that repress the βh1 gene in normal adult erythroid cells. Future work
on optimizing expression levels and testing of additional ZFs or TALE proteins might
further enhance βh1 activation.
The β-globin promoters compete for the actions of the LCR (Stamatoyannopoulos,
2005). It follows that if βh1 transcription is increased in the adult definitive erythroid, a
corresponding decrease in β-major expression is expected, reflecting reduction of
interaction with the LCR. Indeed, β-major expression is reduced compared to controls
(compare the left and right panels in Figure 4.2 C), however at this point we have not
resolved whether this is indeed due to alternate loop formation or a non-specific effect on
cellular differentiation due to βh1 P-SA expression. Follow-up studies will address these
questions.
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Figure 4.1. ZF targeting the βh1 promoter.
(A) Schematic presentation of the murine β-globin locus and the target site of βh1 PZF. (B) ChIP profile of the flag tagged βh1 P-SA (named as 86SA in the figure) in G1E
cells.
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Figure 4.2. Re-activation of βh1 in adult erythroid cells by ZF-SA fusion protein.
(A) βh1 transcript level in G1E cells expressing indicated constructs. (A) βh1
transcript level in estradiol-induced G1E-ER4 cells (estradiol treatment for 48 hours)
expressing indicated constructs. (C). βmaj and βh1 transcript levels in G1E or induced
G1E-ER4 cells expressing empty construct or L-SA+P-SA are plotted in the form of
stacked column charts. Transcript levels are normalized to β-actin.
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4.2.2: Re-activation of the human fetal globin gene
The β-globin disorders, sickle cell disease (SCD) and β-thalassemia, are the most
common genetic disorders in the world. However, there are numerous challenges and
limitations with current treatments (Sankaran, 2011). A series of important natural
observations demonstrated that increased production of fetal hemoglobin, composed of γglobin and α-globin, could ameliorate the severity of SCD and certain forms of βthalassemia. Therefore, understanding the regulatory mechanisms of the β-globin locus
and re-activating the fetal γ-globin genes in adult human erythroid cells have been the
major goals in the field in the past few decades. In our preliminary studies, targeting the
SA domain to the βh1 promoter re-activated βh1 transcription up to ~20% of total βglobin. This is very encouraging since ~15 to 20% of fetal hemoglobin is thought to be
necessary to virtually eliminate SCD phenotypes in patients (Platt et al., 1994).
Therefore, our goal is to investigate whether a forced chromatin loop can be used to
re-activate γ-globin expression in adult human erythroid cells, with the hope to eventually
provide better therapy for SCD and β-thalassemia. To this end, we will first perform
proof-of-principle experiments using human CD34+ HSCs isolated from healthy bone
marrow aspirates, mobilized peripheral blood, or from umbilical cord blood from healthy
newborns. Human HSCs can be expanded for several days and differentiated into
erythroid cells in liquid culture with proper cytokines. TALE or ZF proteins will be
designed and tested to target the human γ-globin promoters. Suitable TALE or ZF
proteins will be fused with the SA domain and introduced into primary human HSCs
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followed by in vitro differentiation into erythroid lineage. Their activities on transcript
and protein levels of hemoglobin will be measured by RT-qPCR and HPLC respectively.
If successful, re-activation of γ-globin can be further studied in various mouse models
carrying the wild type or mutant human β-globin locus as a transgene (Miccio and
Blobel, 2010).
In summary, we hope to be able to demonstrate that forced chromatin looping can be
used to reprogram the murine and human β-globin loci.

Concluding Remarks
This work studied basic mechanisms of transcription regulation using the
hematopoietic system as a model. It demonstrates how numerous transcription factors
interplay on the chromatin to concertedly control transcription activity of genes, and how
each factor plays distinct roles in building a hierarchy of transcription regulation events.
It also shows a vivid example of how novel technologies can be taken advantage of to
study fundamental biological questions. Importantly, it showcases how knowledge
learned from basic research can provide strategies for rational designed therapy.
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CHAPTER 5: Material and Methods
Cell culture of cell lines
G1E cells, G1E-ER4 cells and derivatives expressing Bcl-XL were maintained as
described (Weiss et al., 1997). Where indicated, G1E-ER4 cells were treated with 100nM
estradiol (E2) for 21 hours (3C assays) or 24 hours (RT-qPCR and ChIP assays) to
activate GATA1-ER (indicated as G1E+GATA1 in figures). The murine megakaryocytic
line L8057 (Ishida et al., 1993) was obtained from Dr. Katya Ravid (Boston University
School of Medicine) and maintained in F-12 nutrient mixture (Invitrogen) with 100U/mL
penicillin, 100 U/mL streptomycin, 2 mM L-glutamine and 10% fetal bovine serum
(HyClone, Logan, UT).
MEL cells, PlatE cells, and 293T cells were cultured in DMEM with 10% fetal bovine
serum, 2% penicillin-streptomycin, 1% glutamine, and 1% Na pyruvate. MEL
differentiation was performed by adding 1.5% DMSO to the growth medium for 72 hr.
Isolation and culture of BMMC
Murine bone marrow mast cells (BMMC) were obtained from bone marrow harvested
from 5- to 6-week-old mice and differentiated with 5 ng/ml recombinant IL-3 and 12.5
ng/ml SCF in complete RPMI medium (15% heat-inactivated FBS, 2 mM glutamine, 1%
penicillin-streptomycin, 1 mM sodium pyruvate, and 50 mM 2-β-ME). At 6–8 weeks of
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culture, these populations were almost (>95%) pure mast cells as assessed by KIT and
FcεRI expression and toluidine blue staining (Gregory et al., 2006).
Fetal liver erythroblasts
Wild type fetal liver erythroid cells were obtained from CD1 mice (Charles River
Laboratories). ∆LCR/∆LCR mice (129 strain) were described (Bender et al., 2000). To
generate ∆LCR/wt mice, ∆LCR/∆LCR male animals were bred with wild type female
mice (BL6 strain). E13.5 fetal liver cells were harvested, stained with PE-conjugated
anti-CD71 and APC-conjugated anti-Ter119 antibodies and sorted by FACS. The R1
(Ter119-, CD71 -/low) populations were isolated, infected with desired retrovirus and
cultured for 24 h in proliferation medium containing Iscove’s DMDM supplemented with
15% fetal bovine serum, 1% penicillin-streptomycin, 1% glutamine, 10 ng/mL mIL3, 20
ng/mL m/h IL6, 50 ng/mL mSCF, and 10 ng/mL m/h FLT3L from Peprotech. Where
indicated, cells were induced to differentiate by cultured in Iscove’s DMDM
supplemented with 15% fetal bovine serum, 1% penicillin-streptomycin, 1% glutamine,
50 ug/mL ascorbic acid, 200 ug/mL holotransferrin (Sigma), and 2 U/mL Erythropoietin
ALFA (Epogen).
Transient transfections
K562 cell transfections and firefly luciferase reporter assays were performed as described
previously (Wang et al., 2006). Samples were tested in quadruplicate and each construct
was tested in at least two independent experiments.

144

Retrovirus production and cell infections
Retroviruses were packaged using ecotropic packaging plasmids (pCL-Eco, containing
Gag, Pol and Env genes) in PlatE cells or 293T cells. The virus-packaging PlatE cells
(provided by Dr. Mitchell Weiss) at 80% confluence were transfected by use of
Lipofectamine 2000. Forty-eight hours after transfection, the viral supernatant was
collected, and 5 ml of viral supernatant was mixed with 4 × 106 of G1E-ER4 cells in the
presence of 8 µg/ml polybrene and 10 mM HEPES and spun at 3200 g for 1.5 hours at
room temperature. Cells were then incubated at 37°C for 3 hrs and additional 5 ml of
fresh media was added. After 48 hrs GFP-positive G1E-ER4 cells were purified by
FACS. Cultures were harvested 3-4 days after infection.
The early passage 293T cells at 80% confluence were transfected by use of calcium
phosphate transfection reagent. Viral supernatant was collected twice at 24- and 48hours after transfection. 0.5-2 mL viral supernatant was mixed with up to 4 million G1E
cells or fetal liver cells using 6-well plate in the presence of 8 µg/ml polybrene and 10
mM HEPES and spun at 3200 g for 1.5 hours at room temperature. For isolated primary
fetal liver cells, spin-infection condition was modified to 2,000 rpm at room temperature
for 1 hour, and cells were switched to fresh medium immediately after infection.
ChIP and ChIP-on-chip assays
ChIP was performed as described (Letting et al., 2003). DNA was quantified by using
real-time PCR with SYBR Green dye on an ABI Prism 7900 system (PE Applied
Biosystems). Primer sequences are listed in Supplemental Materials. Results were
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normalized to unprecipitated chromatin (input). All data shown are the averages of three
or more independent experiments. Error bars represent standard deviations.
For ChIP-on-chip analysis, 10 ng of immunoprecipitated DNA or, as control,
unprecipitated chromatin from parental G1E cells and estradiol-treated (24 hr) G1E-ER4
cells was amplified by ligation-mediated PCR using the Whole Genome Amplification
Kit 2 (Sigma). Real time PCR was employed to confirm that the amplification was linear
and had not distorted the proportion among the signals (not shown). Samples from three
independent ChIP experiments were pooled and hybridized to the NimbleGen array 16
from the mm6 version of the high density tiling array (1 array per sample). The
microarray covered 66 Mb of mouse chromosome 7 (positions 63331168 to 129534093
(according to the March 2005 annotation) at 100 bp resolution such that the beginning of
each 50 nucleotide probe is 100 bp away from the start of the adjacent probe in
chromosomal coordinates.
The hybridization signals were analyzed with two peak-calling programs, Mpeak (Zheng
et al., 2007) and Tamalpais (Bieda et al., 2006), at their highest stringencies (3 standard
deviations above the mean for all hybridization signals and L1, respectively). The signal
intensities are also displayed as custom tracks in the UCSC Genome Browser for analysis
by inspection (Kent et al., 2002). The correlations between signal intensities were
computed using the R statistical package (http://www.r-project.org/index.html), and
analysis of peaks was done with tools in Galaxy (Blankenberg et al., 2007).
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RT-qPCR
RNA was extracted with Trizol (Invitrogen) from 105-106 cells. RNase-free glycogen
(Invitrogen) was added to aid RNA precipitation. Reverse transcription reactions were
performed with random hexamers using Superscript II (Invitrogen). Results were
quantified by using real-time PCR with SYBR Green dye on ABI Prism 7000 system.
Allele-specific qPCR was carried out at annealing temperature 62°C (60°C for
conventional qPCR as default setting). Data were normalized to β-actin or GAPDH, both
producing similar results.

3C assay
Detailed 3C protocol is presented in Chapter 3.6. Briefly, the 3C assay was performed as
described (Jing et al., 2008; Vakoc et al., 2005) with the following modifications. 1x107
cells were crosslinked with 1.5% formaldehyde at room temperature for 10 min, followed
by glycine quenching, cell lysis, Bgl II digestion and T4 ligation. 3C ligation products
were quantified in triplicates by quantitative TaqMan real-time PCR. Probes and primers
were designed using Primer Express 2.0 software (Applied Biosystems) and tested by
serial dilution and gel electrophoresis to ensure specific and linear amplification.
Digestion efficiencies were monitored by SybrGreen qPCR with primer pairs that
amplify genomic regions containing or devoid of BglII digestion sites. A BAC clone
containing the entire murine β-globin locus of 129 origin (SourceBioscience, Clone #
BMQ433I10) was digested with BglII and re-ligated to generate random ligation products
of BglII fragments. The DNA was serially diluted and used to generate a standard curve
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to which all 3C products were normalized. The 3C signals at the β-globin locus were
further normalized to those from four intervening regions or, alternatively that of a
control locus ERCC3, both producing similar results.

Antibodies
The following antibodies were used: GATA1 (sc-265; Santa Cruz), GATA2 (sc-9008),
CBP (sc-369), Ldb1 (sc-11198; Santa Cruz), E2A (sc-349; Santa Cruz), ETO-2 (sc 9739
and sc 9741; Santa Cruz), LMO2 (R&D Systems), pan-Pol II (sc-899, Santa Cruz),
CDK9 (sc-484, Santa Cruz), Ser5ph (MS-134R, Covance), H3K4me3 (07-473,
Millipore), anti-HA monoclonal antibody was clone 12CA5. SCL was a gift from Dr. C.
Porcher (University of Oxford) or SCL (sc-12984; Santa Cruz).
Artificial zinc finger design
ZFs each containing six Cys2-His2 zinc finger domains and targeting 18-19 bp sites
within either the β-major promoter or DNase1 hypersensitive site 2 of the mouse LCR
were designed and assembled from two-finger units as previously described (Bartsevich
et al., 2003).
Constructs
Retroviral vectors with HA-SCL and HA-SCL(RER) (provided by C. Porcher) were
inserted into MSCV MIGR1-GFP (Pear et al., 1993). The LMO2 shRNA expression
construct: pSM2 plasmids containing the shRNA against LMO2 was obtained from
148

Open Biosystems: Clone Id V2MM_29885. shRNA encoding fragment was transferred
into pMSCV/LTRmiR30-PIG using XhoI/EcoRI restriction sites.
Individual zinc finger protein coding sequences were cloned into MigR1 retroviral vector
with three HA tags and a nuclear localization signal (NLS) at their N-termini. Full length
Ldb1 or the SA domain containing amino acids 1-200 of Ldb1 was cloned in frame Cterminal to the ZF. P-∆SA was generated by deleting the first 256 amino acids of Ldb1.
ChIP qPCR primers
HS3
Forward 5′-CTAGGGACTGAGAGAGGCTGCTT-3′
Reverse 5′-ATGGGACCTCTGATAGACACATCTT-3′
HS2
Forward 5′-GGGTGTGTGGCCAGATGTTT-3’
Reverse 5′-CACCTTCCCTGTGGACTTCCT-3’
HS1
Forward 5′-CAGATCCTCAAACACTCTCCCATAA-3’
Reverse 5′-TGCCTTCTTTGTCCCATCATT-3’
ey promoter
Forward 5′-ATGACCTGGCTCCACCCAT-3′
Reverse 5′-TCTTTGAAGCCATTGGTCAGC-3′
βh1 promoter
Forward 5′-AGGTCCAGGGTGAAGAATAAAAGG-3′
Reverse 5′-ATCTCAAGTGTGCAAAAGCCAGA-3′
βmaj promoter
Forward 5′-CAGGGAGAAATATGCTTGTCATCA-3′
Reverse 5′-GTGAGCAGATTGGCCCTTACC-3′
βmaj exon 2
Forward 5'-AACGATGGCCTGAATCACTTG-3'
Reverse 5'-AGCCTGAAGTTCTCAGGATCC-3'
βmaj intron 2
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Forward 5’-CTTCTCTCTCTCCTCTCTCTTTCTCTAATC-3’
Reverse 5′-AATGAACTGAGGGAAAGGAAAGG -3’
βmaj 3UTR
Forward 5’- GCCCTGGCTCACAAGTACCA -3’
Reverse 5′- TTCACAGGCAAGAGCAGGAA -3’
βmaj -1kb
Forward 5’-GTATGCTCAATTCAAATGTACCTTATT-3’
Reverse 5′-TTACCTCTTTATTTCACTTTTACACAT-3’
βmin promoter
Forward 5′-GAGCCAGCATTGGGTATATAAAGC-3′
Reverse 5′-ACAGACTCAGAAGCAAACGTAAGAAG-3′
IVR16
Forward 5′-TGGCCATTTTTACTATGTTAATTTTGC-3′
Reverse 5′-TAGACTTGTCATGGTTATGGATTGG-3′
mCD4
Forward 5′-CCAGAACATTCCGGCACATT-3′
Reverse 5′-GGTAAGAGGGACGTGTTCAACTTT-3′
Band 3 promoter
Forward 5′-CTGAGCAGTCAAGCCTTAGTTCAC-3′
Reverse 5′-CCTGTCCAGTCCCTAAGGTCTTT-3′
KLF1 promoter
Forward 5′-TCTGCTCAAGGAGGAACAGAGCTA-3′
Reverse 5′-GGCTCCCTTTCAGGCATTATCAGA-3′
Eraf promoter
Forward 5′-TGCCTGCGTCTCGCTTAGT-3′
Reverse 5′-GCTGAGCCCGCCTCATC-3′
Hba-a1 -31kb
Forward 5′- TTCTGACCTCACCTCAGCTAAGC-3′
Reverse 5′- TGTGTGGGCAGAGGACACA-3′
Hba-a1 -12kb
Forward 5′-AACCCTGACTCAAAACAACAAAGTAA-3′
Reverse 5′- GGTTTCTGAGTTTCCTTATCTGCAA-3′
Hba-a1 promoter
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Forward 5′- TGACCAAGGTAGGAGGATACTAACT-3′
Reverse 5′- TTGCCCGGACACACTTCTTAC-3′
Kit -114kb
Forward 5′- GCACACAGGACCTGACTCCA-3′
Reverse 5′- GTTCTGAGATGCGGTTGCTG -3′
Kit promoter
Forward 5′-CACCTCCACCATAAGCCGAAT-3′
Reverse 5′-CTCCTAGACAATAAAGGACAACCA-3′
Kit +5kb
Forward 5′-GGCTGGAAACCACTGCCTTA-3′
Reverse 5′- AGCCTTGCCTGTGCTTAAAGC -3′
Kit +58kb
Forward 5′-GGAGGAGTTAGGGAATATGTCGATAG-3′
Reverse 5′-GCAGTTCTCCAGGTTGAGTCAGA-3′
Kit +73kb
Forward 5′-AACTGAAGCGAGTACAGCATTCC-3′
Reverse 5′-TGCTTTTGCTTGTGTACTGTTAACTG-3′
Gata2 -77kb
Forward 5′-TGGGCCACCTTCTTTACCAC-3′
Reverse 5′-CCGGAATTCATGCAATGCT-3′
Gata2 -3.9kb
Forward 5′-GAGATGAGCTAATCCCGCTGTA-3′
Reverse 5′-AAGGCTGTATTTTTCCAGGCC-3′
Gata2 -2.8kb
Forward 5′-GCCCTGTACAACCCCATTCTC-3′
Reverse 5′-TTGTTCCCGGCGAAGATAAT-3′
Gata2 1S promoter
Forward 5′-CCCCTCGAAGTGATGTCGAA-3′
Reverse 5′-TCTGGCTGTCTCTCGGTTCC-3′
Gata2 +9.5kb
Forward 5′- ACATCTGCAGCCGGTAGATAAG-3′
Reverse 5′-CATTATTTGCAGAGTGGAGGGTATTA-3′
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Lyl1 promoter
Forward 5′- TTTCCCCTTTGCACACGTTT-3′
Reverse 5′-AAGACCCCCCAACCCTCA-3′
Rgs18 promoter
Forward 5′- AGATTGGTCTTGTACTGAATTGTTGAA-3′
Reverse 5′-ACGCTGTGGTAATACCAGCTTTTA-3′
Etv6
Forward 5′- TGCCAAAACAAATGTAAGAGAGTGA-3′
Reverse 5′- TCCACAGGAAGTTCCCAAGATCT-3′
Sox6
Forward 5′- CCCACCAGTCAGCAGATGT-3′
Reverse 5′- CTGCATCCATTTTGCTGGT-3′
Tram2
Forward 5′- TCATTATCTTGCCTGAACAGATG-3′
Reverse 5′- ATGTGTTCTGTTTTCACTGAGGAT-3′
GPIb promoter
Forward 5'-TGGTGGCTAGTAGCTGCAAAGTC-3'
Reverse 5'-TTATCAGCTCTCTGCACAGCATTC-3'
PF4 promoter
Forward 5'-GCTGCTGGCCTGCACTTAAG-3
Reverse 5'-GCCACTGGACCCAAAGATAAAG-3
cMpl promoter
Forward 5′-CTGCCAACAGAAGGCTCATG-3'
Reverse 5′-CTGTCAGATACAGCCCCACGT-3'
IIb promoter
Forward 5′-GCCATGAGCTCCAGTCTGATAA-3'
Reverse 5′-AGCTCTTTCCCTTTCCCTGAA-3'
IIb -3kb
Forward 5'-AAATAGATGTCAAGTTGGCATAAACCT-3'
Reverse 5'-TGCCAGCGTTCAAGTACAAAA-3'
Mc-cpa promoter
Forward 5'-GGCTTGATCTGACCCCTATACG-3'
Reverse 5'-CCCAGGAACCACAAAGGAAA-3'
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Mc-cpa +3kb
Forward 5'-TGTGGAAGAGAGGGAAGAAGAACT-3'
Reverse 5'-TTGTGTCTAGAAGTGACAGTCTTGCA-3'
Sfpi1 -8kb
Forward 5'-GAAATCCCCACCTCCTAACC-3'
Reverse 5'-TAGGGACCTCAGGCTCTTTGTC-3'
Sfpi1 promoter
Forward 5'-TTCCTGTAGCGCAAGAGATTTATG-3'
Reverse 5'- GCAGGGCCAGCACAAGTTCC-3'
Fc RI-β promoter
Forward 5'-ACAGCAAGAGAAAGGAGTCACTGAT-3'
Reverse 5'-CATGCGGAACCTACTTGTCAGA-3'
Fc RI-β +7kb
Forward 5'-GAAGGTAGTCAATGGGAATGACAA-3'
Reverse 5'-TGTGCTGAGATTCTAGGCAAACA-3'

Transcript qPCR primers
βmaj 5 UTR
Forward 5'-CAACCCCAGAAACAGACATC-3'
Reverse 5'- CAACTTCATCGGCGTTCA-3'
βmaj exon 2
Forward 5'-AACGATGGCCTGAATCACTTG-3'
Reverse 5'-AGCCTGAAGTTCTCAGGATCC-3'
βmaj-D
Forward 5'-GCCTGTGGGGAAAGGTGAACT -3'
Reverse 5'-CCATCGTTAAAGGCAGTTATCACC -3'
βmaj -S
Forward 5'- GCCTGTGGGGAAAGGTGAACG-3'
Reverse 5'- GCCATCGTTAAAGGCAGTTATCACT -3'
βmaj intron 2
Forward 5’-CTTCTCTCTCTCCTCTCTCTTTCTCTAATC-3’
Reverse 5′-AATGAACTGAGGGAAAGGAAAGG -3’
153

βmaj exon 2/3
Forward 5'- AGCTCCACTGTGACAAGCTG -3'
Reverse 5'- CCAGCACAATCACGATCATA -3'
βmaj 3UTR
Forward 5’- GCCCTGGCTCACAAGTACCA -3’
Reverse 5′- TTCACAGGCAAGAGCAGGAA -3’
βh1
Forward 5’- AGGCAGCTATCACAAGCATCTG -3’
Reverse 5′- AACTTGTCAAAGAATCTCTGAGTCCA -3’
Hba
Forward 5'- GTGGATCCCGTCAACTTCAAG -3'
Reverse 5'- CAAGGTCACCAGCAGGCAGT -3'
Slc4a1
Forward 5'-TGGAGGCCTGATCCGTGATA-3'
Reverse 5'-AGCGCATCGGTGATGTCA-3'
Alas2
Forward 5'-CCATCTTAAGGCAACCAAGGC -3'
Reverse 5'- ACAGCATGAAAGGACAATGGC-3'
Klf1
Forward 5'-TTCCGGAGAGGACGATGAGA-3'
Reverse 5'-AACCTGGAAAGTTTGTAAGGAAAAGA-3'
Gata1
Forward 5'- GCCCAAGAAGCGAATGATTG-3'
Reverse 5'- GTGGTCGTTTGACAGTTAGTGCAT-3'
Gata2
Forward 5'-CACCCCTAAGCAGAGAAGCAA-3'
Reverse 5'-TGGCACCACAGTTGACACACT-3'
Kit
Forward 5'-AGCAGATCTCGGACAGCACC-3'
Reverse 5'-TGCAGTTTGCCAAGTTGGAG-3'
Gapdh
Forward 5'- GATGCCCCCATGTTTGTGAT-3'
Reverse 5'-GGTCATGAGCCCTTCCACAAT-3'
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β-actin
Forward 5'- ACACCCGCCACCAGTTC -3'
Reverse 5'- TACAGCCCGGGGAGCAT -3'
Lyl1
Forward 5'-CCTGACCTGGACTGACAAACCT-3'
Reverse 5'-CACATGGACCCCACGGATA-3'
Rgs18
Forward 5'-TAATGCATGGGTCAGGGAAAG-3'
Reverse 5'-TCAGGCCTCTGTAGGAGAAGACTTAG-3'
Pabpc1
Forward 5'-CTACCAGCCAGCACCTCCTT-3'
Reverse 5'-TGCAGCACGGTTCTGAGTCT-3'
LMO2 shRNA ‘sense’ sequences
5’-CCCAGCCCTTAGAGAGAATTTA-3'
3C probes and primers
β-globin locus
LCR-HS2 probe

56-FAM/TCT GCC TGT CCC TGC CTC GTG A/36-TAMSp

Anchor primer (rHS2)

I (rHS1)

5'- CAGCGTTTTAGTTGGATATAGAGTGAA-3'

5'- GAACTTGTCAGGGAATTACCTAGTACAG -3'

II (rbh1ey)

5'- GATCCCTATTGTCTACTTTTGCCAG-3'

III (rbh1)

5'- CCCATGTTACACCCCATTACAAG-3'

IV (rβmaj)

5'- GGCTGGAACATCACTGGAATAAAT-3'

V (rβmaj-frag2)

5'- CAGTCGAGGAATGCAACTGTGA-3'

VI (rIVR3)

5'-AAGACTAAAAATCCCAGATTGATTCC-3'

VII (rbmin)

5'-GCCAAATCAGGACCCTAACATT-3'
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VIII (rIVR2)

5'-CCAAGTCTCTCAAGAAAGAAATCGA-3'

X (rIVR1)

5'-CAAACATAAGACCATAAGCAACAGAAA-3'

XI (r3HS1)

5'- ACTACCTAACTCTCAAAAATCTGTGTGA-3'

XII (r3OR)

5'-GAAAAAATGTGTACGCATCATTAGTTATG-3'

ERCC3 locus
ERCC3 probe

56-FAM/TCTAGAGCCAAACTCTCCAGCCACCACTTC/36-TAMSp

rERCC3_3

5'-GCAGTGAAAACACAACACAGTTAATATG-3'

rERCC3_5

5'-GCAGCCACCGACTTGGAT-3'

Primers for 3C digestion efficiency
HS2 BglII cut #1
Forward 5′- TGTAGATCAGGATTGACTGGTAC -3’
Reverse 5′- CAGCGTTTTAGTTGGATATAGAGTGAA -3’
HS2 BglII uncut #1
Forward 5′-GGGTGTGTGGCCAGATGTTT-3’
Reverse 5′-CACCTTCCCTGTGGACTTCCT-3’
HS2 BglII cut #2
Forward 5′- GCGTTTTAGTTGGATATAGAGTGAAGG -3’
Reverse 5′- TGCTATCATGGAACATACTATGTAGATCA -3’
HS2 BglII uncut #2
Forward 5′- AGGAACAGGCAAGGCAGCTT -3’
Reverse 5′- TCACTGGTACCCTGTTTCCTTATCT -3’
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